BigBear.ai Holdings, Inc.
For the period ended Dec 31, 2025. Filed Mar 2, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 2, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
Note 1—Description of the Business
BigBear.ai Holdings, Inc.’s (“BigBear.ai”, “BigBear.ai Holdings”, “BigBear” or the “Company”) mission is to help deliver clarity for the world’s most complex decisions. BigBear.ai is a leading provider of Edge AI-powered decision intelligence solutions for national security, supply chain management and digital identity. Customers and partners rely on BigBear.ai’s predictive analytics capabilities in highly complex, distributed, mission-based operating environments. We are a technology-led solutions organization, providing both software and services to our customers. Unless otherwise indicated, references to “we”, “us” and “our” refer collectively to BigBear.ai Holdings, Inc. and its consolidated subsidiaries.
Note 2—Summary of Significant Accounting Policies
Basis of Presentation
The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and all intercompany balances and transactions have been eliminated in consolidation. Amounts presented within the consolidated financial statements and accompanying notes are presented in thousands of U.S. dollars unless stated otherwise, except for percentages, units, shares, per unit, and per share amounts.
Use of Estimates
The preparation of theconsolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of theconsolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of theconsolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, actual results could differ materially from those estimates. Accounting policies subject to estimates include valuation of goodwill, intangible assets, impairments, fair value remeasurements, capitalized software development costs, revenue recognition, income taxes, business combinations and equity-based compensation.
Business Combinations
The Company utilizes the acquisition method of accounting under ASC 805, for all transactions and events in which it obtains control over one or more other businesses (even if less than 100% ownership is acquired), to recognize the fair value of all assets and liabilities assumed and to establish the acquisition date fair value as of the measurement date.
While the Company uses its best estimates and assumptions as part of the purchase price allocation process to accurately value assets acquired and liabilities assumed as of the acquisition date, the estimates and assumptions are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. For changes in the valuation of intangible assets between the preliminary and final purchase price allocation, the related amortization is adjusted in the period it occurs. Subsequent to the measurement period, any adjustment to assets acquired or liabilities assumed is included in operating results in the period in which the adjustment is determined. Transaction expenses that are incurred in connection with a business combination, other than costs associated with the issuance of debt or equity securities, are expensed as incurred.
Revenue Recognition
The Company’s revenues from contracts with customers are from offerings including artificial intelligence (“AI”) and machine learning, generative AI, data science, advanced analytics, offensive and defensive cyber, data management, cloud solutions, digital engineering, and systems integration, primarily with the U.S. Government and its agencies. The Company also serves manufacturing, third party logistics, retailers, healthcare, and life sciences organizations.
The Company organizes its solutions into five markets:
i. Supply Chain & Logistics Solutions: Data Conflation at Scale (providing a full view of operations, enabling real-time tracking of inventory, and facilitating predictive analytics to optimize functions like routes and delivery times), Discrete Event Simulation (Course of Action Analysis & Digital Twins), and Next-Gen Decision Support (e.g. Macroeconomic & Geopolitical Forecasting)
ii. Cybersecurity Solutions: AI-powered / machine-accelerated binary analysis, Cyber-Physical systems vulnerability testing & evaluation, Vulnerability assessment as a Service, and Specialized services for the Department of Defense and Intelligence Community
iii. Autonomous Systems Solutions: AI/machine learning (“ML”) decision intelligence solutions (conflate millions of data points to provide situational awareness, predictive forecasts, and anomaly detection), AI Orchestration as a Service, and specialized consulting services
iv. Digital Identity Services: security solutions specializing in customized digital identity, biometrics, AI/ML, and advanced analytics software and solutions for global trade, travel and digital identity industries. Airlines, airports and US government agencies are among the Company’s customers relying on Vision AI, analytics capabilities, and expertise to streamline operations, secure facilities and verify identity.
v. Ask Sage Platform: generative AI platform purpose-built for secure AI deployment, orchestration, and agentic capabilities across defense, intelligence, and other highly regulated environments. Ask Sage leverages cutting-edge third-party large language models (LLMs) to offer multi-modal generative AI capabilities, including text, speech-to-text, text-to-speech, image recognition and image generation.
Each of the Company’s solutions can be sold individually or combined and sold together. Regardless of whether a customer is procuring only one of the Company’s solutions or a combination of solutions, the Company’s contracts typically include a significant service of integrating the solutions with the Company’s customer’s existing solutions and information systems. After the Company implements the solutions, the Company may also enter into contracts with the customers to further refine or customize these solutions to either enhance the functionality or adjust for changes in the customer’s requirements. These post-implementation service contracts are generally performed on a time-and-materials basis.
The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. The Company performs under various types of contracts, which generally include firm-fixed-price (“FFP”), time-and-materials (“T&M”), and cost-reimbursable contracts. The Company also generates revenues from the sale of software-as-a-service (“SaaS”) subscriptions and software licenses, which include ongoing maintenance and support services (“M&S”).
Under fixed-price contracts, the Company agrees to perform the specified work for a pre-determined price. To the extent the Company’s actual costs vary from the estimates upon which the price was negotiated, the Company will generate more or less profit or could incur a loss. Under T&M contracts, the Company agrees to perform the specified work for a pre-determined rate per hour, as well as the reimbursement of other direct billable costs which are presented on a gross basis. Cost-reimbursable contracts provide for the payment of allowable costs incurred during performance of the contract plus a fee up to a ceiling based on the amount that has been funded. The majority of our cost-reimbursable contracts are cost-plus-fixed-fee, which provide a fixed fee that is negotiated at the inception of the contract and does not vary with actual costs.
For T&M contracts and cost-reimbursable contracts, the Company has a right to consideration from the customer in an amount that corresponds directly with the value of the Company’s performance and recognizes revenue in the amount to which the Company has a right to invoice (the “right to invoice” practical expedient).
Sales of the Company’s software licenses, primarily term licenses, grant customers the right to use functional intellectual property, either on their internal hardware infrastructure or on their own cloud instance, over the contractual term. The Company’s SaaS subscriptions grant customers the right to access the software functionality in a hosted environment controlled by BigBear. The Company agrees to provide continuous access to its hosted software platforms throughout the contract term.
Both software licenses and SaaS subscriptions are also sold together with stand-ready M&S services. The M&S services include critical updates, training, support, and maintenance services required to operate the software. The Company has concluded that the software licenses and M&S services are distinct performance obligations.
The Company assesses each contract at its inception to determine whether it should be combined with other contracts. When making this determination, the Company considers factors such as whether two or more contracts were negotiated and executed at or near the same time or were negotiated with an overall profit objective. If combined, the Company treats the combined contracts as one single contract for revenue recognition purposes.
The Company generally uses internally developed and third-party applications, which the Company integrates, when implementing solutions to meet specific customer requirements. The Company evaluates the solutions or services promised in each contract at inception to determine whether the contract should be accounted for as having one or more performance obligations. Each of the Company’s solutions is capable of being distinct as the customer can benefit from each individual solution on its own or with other resources that are readily available. When customer contracts include a significant service of integrating the solutions to provide a set of integrated or highly interrelated tasks, the Company accounts for these arrangements as a single performance obligation. While the contracts provide customers access to the Company’s solutions, the contracts generally do not contain separate licensing provisions for independent use of the underlying internally developed software. Additionally, these components are highly interdependent and highly interrelated into the solutions delivered to the Company’s customers. Therefore, these components are not capable of being distinct and are not separately identifiable from the other promises in the contract. In cases where customer contracts have an explicit licensing provision to the underlying software, such software is generally accounted for as a separate performance obligation.
The Company determines the transaction price for each contract based on the consideration the Company expects to receive for the solutions or services being provided under the contract. For contracts where a portion of the price may vary, the Company estimates variable consideration at the most likely amount, which is included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. The Company analyzes the risk of a significant revenue reversal and if necessary, constrains the amount of variable consideration recognized in order to mitigate this risk.
At the inception of a contract, the Company estimates the transaction price based on its current rights and does not contemplate future modifications (including unexercised options) or follow-on contracts until they become legally enforceable. Contracts are often subsequently modified to include changes in specifications, requirements or price, which may create new or change existing enforceable rights and obligations. Depending on the nature of the modification, the Company considers whether to account for the modification as an adjustment to the existing contract or as a separate contract. The Company’s contracts with the U.S. Government often contain options to renew existing contracts for an additional period of time (generally a year at a time) under the same terms and conditions as the original contract, and generally do not provide the customer any material rights under the contract. The Company accounts for renewal options as separate contracts when they include distinct goods or services at standalone selling prices.
For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation based on the estimated standalone selling price of the solution or service underlying each performance obligation. The standalone selling price represents the amount (or a range of amounts) for which the Company would sell the solution or service to a customer on a standalone basis (i.e., not bundled with any other solutions or services). The Company’s contracts with the U.S. government are subject to the Federal Acquisition Regulation (“FAR”) and priced on estimated or actual costs of providing the goods or services. The FAR provides guidance on types of costs that are allowable in establishing prices for goods and services provided to the U.S. government and its agencies. Each contract is competitively priced and bid separately. Pricing for non-U.S. government agencies and commercial customers is based on specific negotiations with each customer. In circumstances where the standalone selling price is not directly observable, the Company estimates the standalone selling price using the expected cost-plus margin or residual approach.
The Company recognizes revenue as performance obligations are satisfied and the customer obtains control of the solutions and services. In determining when performance obligations are satisfied, the Company considers factors such as contract terms, payment terms and whether there is an alternative future use of the solution or service. The majority of the Company’s revenue is recognized over time as the Company performs under the contract because control of the work in process transfers continuously to the customer. For most contracts with the U.S. Government, this continuous transfer of control of the work in process to the customer is supported by clauses in the contract that give the customer ownership of work in process and allow the customer to unilaterally terminate the contract for convenience and pay the Company for costs incurred plus a reasonable profit.
For performance obligations to deliver customized solutions with continuous transfer of control to the customer, revenue is recognized based on the extent of progress towards completion of the performance obligation, generally using the percentage-of-completion cost-to-cost measure of progress for the Company’s contracts because it best depicts the transfer of control to the customer as the Company incurs costs on the contracts. Under the percentage-of-completion cost-to-cost measure of progress, the extent of progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs to complete the performance obligation(s). For T&M contracts, revenue is recognized over time based on costs incurred or the right to invoice method (in situations where the value transferred matches the Company’s billing rights) as the customer receives and consumes the benefits.
The Company recognizes revenue from the sale of software licenses upon delivery as this is the moment that control transfers to the customer. Revenue from M&S services provided with software licenses is recognized over the contract term on a ratable basis. Revenue from SaaS subscriptions (including bundled M&S services) is generally recognized over the contract term on a ratable basis, which is consistent with the pattern of benefit of the SaaS subscription to the customer.
For arrangements with the U.S. Government, the Company generally does not begin work on contracts until funding is appropriated by the customer. Billing timetables and payment terms on the Company’s contracts vary based on a number of factors, including the contract type. Cost-reimbursable and T&M contracts are generally billed on a monthly basis. FFP contracts are generally billed based on milestones, which are the achievement of specific events as defined in the contract. Amounts billed and due from customers are classified as receivables on the combined balance sheets. On some contracts, the Company may be entitled to receive an advance payment, which is not considered a significant financing component because it is used to facilitate inventory demands at the onset of a contract and to safeguard the Company from the failure of the other party to abide by some or all of their obligations under the contract.
In some cases where a portion of payment retained by the customer is not considered a significant financing component; the Company expects, at contract inception, that the lag period between the transfer of a promised good or service to a customer and when the customer pays for that good or service will not constitute a significant financing component.
Sale of Products
Revenue from sale of products to customers purchased from third parties is recognized at a point in time when control has transferred to the customer. Control is transferred to the customer upon customer acceptance or receipt of the product. At this point in time, the Company has a present right to payment, and the customer has legal title and physical possession of the product as well as the risks and rewards of ownership.
Contract Balances
Contract balances result from the timing of revenue recognized, billings and cash collections, and the generation of contract assets and liabilities.
Contract assets represent revenue recognized in excess of amounts invoiced to the customer and the right to payment is not subject to the passage of time. Contract liabilities consist of billings in excess of revenues and customer advances. Billings in excess of revenues represents milestone billing contracts where the billings of the contract exceed recognized revenues.
Cash and Cash Equivalents
Cash and cash equivalents are comprised of cash on hand, cash balances with banks and similar institutions and all highly liquid investments with an original maturity of three months or less when purchased.
Restricted Cash
Restricted cash consists of amounts that are not available for general corporate use due to contractual, legal, or regulatory restrictions. The Company presents restricted cash as either current or non-current on the consolidated balance sheets based on the expected timing of the satisfaction of the restrictions or the underlying obligations to which the amounts relate. As of December 31, 2025, the Company’s restricted cash comprises a $4.0 million escrow related to its acquisition of Ask Sage as well as performance bonds held for certain revenue contracts.
Investments in Debt Securities
The Company’s investments in debt securities comprise U.S. Treasury securities and corporate bonds. Certain of our debt securities are either explicitly or implicitly guaranteed by the U.S. Government, are highly rated by major rating agencies, and have a long history of no credit losses.
Debt securities purchased with the positive intent and ability to hold to its maturity are classified as held-to-maturity (“HTM”) securities and are recorded at amortized cost, net of any allowance for credit losses. For debt securities where the Company cannot demonstrate the positive intent and ability to hold to maturity, the investments are classified as available for sale (“AFS”) and are recorded at fair value. Unrealized gains and losses on AFS investments, net of applicable taxes, are reported in other comprehensive (loss) income. For both HTM and AFS investments, accruals of coupon payments and the accretion of discounts and amortization of premiums over the contractual terms of the underlying securities are included in interest income.
Accrued interest receivable on our debt securities was $3.5 million at December 31, 2025, and $— million at December 31, 2024, and is excluded from balances within our disclosures in Note 6—Investments in Debt Securities as it is included and reported separately within prepaid expenses and other current assets in our consolidated balance sheets.
Allowance for Expected Credit Losses of HTM Investments
The Company evaluates HTM debt securities for expected credit losses in accordance with ASC 326, Credit Losses(“ASC 326”). For debt securities that are explicitly or implicitly guaranteed by the U.S. Government, we consider the risk of credit loss to be zero and, therefore, we do not record expected credit losses. The estimate of expected credit losses on our HTM securities that are not guaranteed by the U.S. Government considers historical credit loss information and severity of loss in the event of default and leverages external data adjusted for current conditions. Expected credit losses on HTM securities are measured on a collective basis by major security type and standard credit rating. We do not estimate expected credit losses on accrued interest receivable from HTM securities as accrued interest receivable is reversed or written off when the full collection of the accrued interest receivable related to a security becomes doubtful.
Impairment of AFS Investments
The Company evaluates AFS debt securities for impairment in accordance with ASC 326. When the Company intends to sell an AFS security, or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis, any impairment is recognized through earnings in an amount equal to the difference between the amortized cost basis and fair value. For AFS debt securities that the Company intends to hold, the Company evaluates whether a credit loss exists when the fair value of the security is less than its amortized cost basis. In determining whether a credit loss exists, the Company considers relevant factors, including changes in credit ratings, the financial condition of the issuer, delinquency or default status, and the expected recovery period. When a credit loss is identified, the Company records a credit loss through earnings, with a corresponding adjustment to the allowance for credit losses. The allowance is limited to the amount by which the amortized cost basis exceeds the security’s fair value. Any remaining decline in fair value is attributable to non-credit factors is recorded in other comprehensive loss. The Company does not estimate expected credit losses on accrued interest receivable related to AFS securities, consistent with its policy for HTM securities.
Accounts Receivable
Accounts receivable includes amounts billed and currently due from customers, and unbilled amounts for which the Company has the unconditional right to consideration. The Company generally records a receivable when revenue is recognized as the timing of revenue recognition may differ from the timing of payment from customers. Payment terms and conditions vary by contract, although terms generally include a requirement of payment within 30 to 60 days. The Company's accounts receivables do not bear interest, and they are recorded at the invoiced amount less an estimated allowance for expected credit losses. In addition to estimating an allowance based on specific identification of certain receivables that have a higher probability of not being paid, the Company also records an estimate for expected credit losses for the remaining receivables in the aggregate using a loss-rate method that considers historical bad debts, age of customer receivable balances, and current customer receivable balances. Additionally, the Company considers future reasonable and supportable forecasts of economic conditions to adjust historical loss rate percentages as necessary. Balances are written-off when determined to be uncollectible. The provision for expected credit losses is recorded in selling, general, and administrative expenses in the consolidated statements of operations and comprehensive loss.
Amounts unbilled included within accounts receivable as of December 31, 2025 and December 31, 2024 were $6.0 million and $15.4 million, respectively.
Property and Equipment
Property and equipment are the long-lived, physical assets of the Company acquired for use in the Company’s normal business operations and not intended for resale by the Company. These assets are recorded at cost. Renewals and betterments that increase the useful lives of the assets are capitalized. Repair and maintenance expenditures that increase the efficiency of the assets are expensed as incurred. Assets under capital leases are recorded at the present value of the minimum lease payments required during the lease period. Depreciation is based on the estimated useful lives of the assets using the straight-line method and is included in selling, general and administrative or cost of revenues based upon the asset. Expected useful lives are reviewed at least annually.
Estimated useful lives are as follows:
| Property and equipment | Estimate useful life in years |
|---|---|
| Computer equipment | 3 |
| Furniture and fixtures | 7 |
| Leasehold improvements | 5 or lease term |
| Office equipment | 5-10 |
| Software | 3-5 |
As assets are retired or sold, the related cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations.
The Company regularly evaluates its property and equipment for impairment when events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, in accordance with ASC 360, Property, Plant, and Equipment. If the Company determines that the carrying amount of an asset or asset group is not recoverable based upon the undiscounted expected future cash flows of the asset or asset group, the Company records an impairment loss equal to the excess of carrying amount over the estimated fair value of the asset or asset group.
Finite-lived Intangible Assets
Finite-lived intangible assets result from the Company’s various business combinations and consist of identifiable finite-lived intangible assets, including customer relationships, technology, licenses and certifications, software for sale and trade names. These finite-lived intangible assets are reported at cost, net of accumulated amortization, and are either amortized on a straight-line basis over their estimated useful lives or over the period the economic benefits of the intangible asset are consumed.
The Company regularly evaluates its intangible assets other than goodwill for impairment when events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, in accordance with ASC 360, Impairment and Disposal of Long-Lived Assets. If the Company determines that the carrying amount of an asset or asset group is not recoverable based upon the undiscounted expected future cash flows of the asset or asset group, the Company records an impairment loss equal to the excess of carrying amount over the estimated fair value of the asset or asset group.
At the beginning of December 2025, the Company identified a triggering event related to its asset group. We calculated the undiscounted cash flows of the Company’s asset group and compared these to its carrying value. As the undiscounted cash flows did not exceed its carrying value, the Company estimated the fair value of the asset group, and a result of this valuation, recorded a $53.4 million impairment expense during the year ended December 31, 2025. The impairment expense is presented in impairment of long-lived assets in the consolidated statements of operations and comprehensive loss. Refer to Note 9—Intangible Assets, net for further information.
Leases
The Company determines whether an arrangement is a lease at inception. An arrangement is or contains a lease if it conveys the right to control the use of an asset for a period of time in exchange for consideration. The Company has operating leases for office space, automobiles, and other equipment that expire at various dates through 2030. These lease terms may include optional renewals, terminations or purchases, which are considered in the Company’s assessments when such options are reasonably certain to be exercised.
The Company measures right-of-use assets and related lease liabilities based on the present value of remaining lease payments. Lease contracts may include fixed payments for non-lease components, such as common area maintenance, which are included in the measurement of lease liabilities for certain asset classes based on the Company’s election to combine lease and non-lease components. The Company does not recognize short-term leases, those lease contracts with durations of twelve months or less, on theconsolidated balance sheets.
As applicable borrowing rates are not typically implied within the lease arrangements, the Company discounts lease payments based on its estimated incremental borrowing rate at lease commencement, or modification, which is based on the Company’s estimated credit rating and the lease term at commencement.
Derivatives
Financial instruments subject to the guidance of ASC 815, Derivatives and Hedging(“ASC 815”) that do not meet the criteria for equity treatment are classified as assets or liabilities measured at fair value. The Company remeasures derivative asset or liability to fair value at each reporting period with changes in fair value recognized in the consolidated statements of operations and comprehensive loss.
Fair Value of Financial Instruments
The Company measures certain financial assets and liabilities at fair value. ASC 820, Fair Value Measurement and Disclosures(“ASC 820”), specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair-value hierarchy:
Level 1—Quoted prices for identical instruments in active markets;
Level 2—Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3—Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
These inputs are based on Company’s own assumptions about current market conditions and require significant management judgment or estimation. Financial instruments consist of cash equivalents, accounts receivable, accounts payable, accrued liabilities, private warrants, written put options, and debt. Cash equivalents are stated at fair value on a recurring basis. Accounts receivable, accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt of payment date. Private warrants and written put options are marked to fair value on a periodic basis.
Income Taxes
The Company estimates its current tax expense together with assessing temporary differences resulting from differing treatment of items not currently deductible for tax purposes. These differences result in deferred tax assets and liabilities on the Company’s consolidated balance sheets, which are estimated based upon the difference between the financial statement and tax bases of assets and liabilities using the enacted tax rates that will be in effect when these differences reverse. In general, deferred tax assets represent future tax benefits to be received when certain expenses previously recognized in the Company’sconsolidated statements of operations and comprehensive loss become deductible expenses under applicable income tax laws or loss or credit carry forwards are utilized. Accordingly, the realization of the Company’s deferred tax assets are dependent on future taxable income against which these deductions, losses, and credits can be utilized.
The Company evaluates the realizability of its deferred tax assets and recognizes a valuation allowance when it is more likely than not that a future benefit on such deferred tax assets will not be realized. Changes in the valuation allowance, when recorded, would be included in the Company’sconsolidated statements of operations and comprehensive loss. Management’s judgment is required in determining the Company’s valuation allowance recorded against its net deferred tax assets.
The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. The Company recognizes interest and penalties related to uncertain tax positions in its provision (benefit) for income taxes. As of December 31, 2025 and December 31, 2024, the Company accrued $0.8 million and $0.8 million for uncertain tax positions, respectively.
Concentration of Credit Risk
Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, certificates of deposit, and accounts receivable. The Company places its cash and cash equivalents with financial institutions of high credit quality. At times, such amounts may exceed federally insured limits. Cash and cash equivalents including cash on deposit or invested with financial and lending institutions was$92.6 million and$50.1 million, as of December 31, 2025 and December 31, 2024, respectively.
The Company provides credit to customers in the normal course of business. The carrying amount of current accounts receivable is stated at cost, less an estimated allowance for expected credit losses. The Company performs ongoing credit evaluations of its customers’ financial condition and limits the amount of credit extended when deemed necessary. The Company maintains an allowance for expected credit losses to provide for the estimated amount of accounts receivable that will not be fully collected. The estimate is calculated using a loss-rate method that considers historical bad debts, age of customer receivable balances, and current customer receivable balances. Additionally, the Company considers future reasonable and supportable forecasts of economic conditions to adjust historical loss rate percentages as necessary. Balances are written-off when determined to be uncollectible. As of December 31, 2025, the Company had one customer with an accounts receivable balance of $3.4 million, which exceeds 10% of total accounts receivable. As of December 31, 2024, no individual customer had an accounts receivable balances that exceeded 10% of total accounts receivable.
Segment Information
Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company has concluded that it operates inone operating segment andone reportable segment, consistent with information used by the CODM to assess performance, make operating decisions, and allocate resources. The Company evaluates the operating performance of its one segment based upon information included in management reports.
Goodwill
Goodwill is the amount by which the purchase price exceeded the fair value of the net identifiable assets acquired and liabilities assumed in a business combination on the date of acquisition. Goodwill is assessed for impairment at least annually as of October 1, on a reporting unit basis, or when events and circumstances occur indicating that the recorded goodwill may be impaired. The Company assesses impairment first on a qualitative basis to determine if a quantitative assessment is necessary. In circumstances where the qualitative analysis indicates that it is more likely than not that the fair value of a reporting unit does not exceed its carrying value, the Company performs a quantitative impairment test by which the goodwill impairment loss is measured as the amount by which a reporting unit’s carrying amount exceeds its fair value, not to exceed the carrying amount of goodwill. All indefinite-lived assets are reviewed for impairment annually, and as necessary if indicators of impairment are present.
Internal-Use Software
Costs incurred in developing internal-use software are either capitalized or expensed, depending on both the nature of the costs and the phase of development in which they are incurred. Costs incurred for implementation activities during the preliminary and post-implementation phases of a project are expensed as incurred, while costs incurred during the application development phase are generally capitalized. Costs incurred to upgrade or enhance existing software are capitalized if the changes result in additional functionality, but these costs are expensed if the software’s functionality is not improved. No costs were capitalized during the year ended December 31, 2025 and December 31, 2024.
Capitalized Software Development Costs
Software development costs for software to be sold, leased, or otherwise marketed are expensed as incurred until the establishment of technological feasibility, at which time those costs are capitalized until the product is available for general release to customers and amortized over the estimated life of the product. Software development costs of $3.8 million and $10.6 million were capitalized during the year ended December 31, 2025 and December 31, 2024, respectively.
We evaluate the useful lives of these assets on an annual basis, and we test for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. For the year ended December 31, 2025 and December 31, 2024, we have recognizedno impairments of capitalized software costs.
Equity-based Compensation
Pursuant to ASC 718, Compensation – Stock Compensation, stock-based awards are measured at fair value on the grant date. For equity classified equity-based awards without performance conditions, the Company recognizes equity-based compensation cost on a straight-line basis over the vesting period of the award. For equity classified equity-based awards with performance conditions, the Company recognizes equity-based compensation cost using the accelerated attribution method over the requisite service period when the Company determines it is probable that the performance condition will be satisfied. The Company recognizes forfeitures of equity-based awards in the period they occur.
Research and Development Costs
Research and development costs are primarily made up of labor charges, subcontractor labor costs, prototype material, and development expenses. Research and development costs are expensed in the period incurred.
Advertising Costs
All advertising, promotional and marketing costs are expensed when incurred and are included in selling, general and administrative expenses within the consolidated statements of operations and comprehensive loss.
The table below presents advertising costs for the following periods:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Advertising Costs | $3,599 | $157 | $337 |
Net (Loss) Income per Share
Basic net (loss) income per share is computed by dividing net (loss) income applicable to stockholders by the weighted average number of shares outstanding for the period. Diluted net (loss) income per share assumes conversion of potentially dilutive shares, such as stock options. The Company’s consolidated statements of operations and comprehensive loss include a presentation of net loss per share for the year ended December 31, 2025, December 31, 2024 and December 31, 2023.
Recent Accounting Pronouncements
Recent Accounting Pronouncements Not Yet Adopted
In November 2024, the FASB issued Accounting Standards Update (“ASU”) No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (“ASU 220-40”). The ASU requires disclosure, in the notes to financial statements, of specified information about certain costs and expenses, including purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each relevant expense caption. Additionally, the amendment requires a qualitative description of the amounts remaining in the relevant expense captions that are not separately disaggregated quantitatively, and to disclose the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. For public business entities, the new guidance is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. An entity may apply the amendments prospectively for reporting periods after the effective date or retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the impact of adoption, which is expected to have an impact on disclosures only with no impact on the Company’s results.
In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses - Measurement of Credit Losses for Accounts Receivable and Contract Assets (“ASU 2025-05”). ASU 2025-05 provides a practical expedient that all entities can use when estimating expected credit losses for current accounts receivable and current contract assets arising from transactions accounted for under ASC 606, Revenue from Contracts with Customers. Under this practical expedient, an entity is allowed to assume that the current conditions it has applied in determining credit loss allowances for current accounts receivable and current contract assets remain unchanged for the remaining life of those assets. ASU 2025-05 is effective for fiscal years beginning after December 15, 2025, and interim reporting periods in those years. Entities that elect the practical expedient and, if applicable, make the accounting policy election are required to apply the amendments prospectively. The Company is currently evaluating the impact of ASU 2025-05 on its financial statements and disclosures.
In September 2025, the FASB issued ASU No. 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (“ASU 2025-06”). The ASU eliminates references to project stages and introduces a principles-based “probable-to-complete” capitalization threshold, meaning entities can capitalize internal-use software costs when management has approved and funded the project and it’s probable the software will be completed and used as intended. These changes are intended to reflect current iterative development practices and take effect for annual periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adoption.
In December 2025, the FASB issued ASU 2025-11, Interim Reporting - Narrow-Scope Improvements (“ASU 2025-11”). The amendments in ASU 2025-11 clarify current interim disclosure requirements and provide a comprehensive list of required interim disclosures. The update also incorporates a disclosure principle that requires entities to disclose events that occur after the end of the last annual reporting period. ASU 2025-11 is effective for interim periods within annual periods beginning after December 15, 2027, though early adoption is permitted. The Company does not expect ASU 2025-11 to have a material effect on its consolidated financial statements and disclosures.
Recent Accounting Pronouncements Adopted
In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (“ASU 2023-09”). Under ASU 2023-09, public benefit entities must disclose specific categories and provide additional information in the tax rate reconciliation if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income or loss by the applicable statutory income tax rate. ASU 2023-09 also requires entities to disaggregate income taxes paid by federal, foreign, and state and local jurisdictions, with further breakdown for significant individual jurisdictions. The amendments from ASU 2023-09 are effective for annual periods beginning after December 15, 2024. The Company adopted ASU 2023-09 for the year ended December 31, 2025 on a prospective basis. Refer to Note 14—Income Taxes for additional information.
Note 3—Restructuring Charges
The following table presents the employee separation costs, net of tax, associated with the Company’s organizational restructuring for the following periods, as well as the unpaid employee separation costs remaining related to the organizational restructurings at the end of each period:
| Years Ended December 31, | |||||
|---|---|---|---|---|---|
| 2025 · 2024 · 2023 | |||||
| Employee separation costs | $4,370 | $1,289 | $822 | ||
| As of | |||||
| December 31, 2025 · December 31, 2024 | |||||
| Unpaid employee separation costs | $619 | $— | |||
The table below presents the activity in accrued restructuring charges for the year ended December 31, 2025:
| As of December 31, 2022 | $1,535 |
|---|---|
| Additions | 822 |
| Settlements | (2,357) |
| As of December 31, 2023 | $— |
| Additions | 1,289 |
| Settlements | (1,289) |
| As of December 31, 2024 | $— |
| Additions | 4,370 |
| Settlements | (3,751) |
| As of December 31, 2025 | $619 |
The restructuring expenses for all periods presented are recorded in the restructuring charges line on the consolidated statements of operations and comprehensive loss. The restructuring accrual is included in the accrued liabilities line in the consolidated balance sheets.
The total charges for the 2024 restructuring event were $1.3 million and as of December 31, 2024, there wereno remaining payments to be made.
The total charges for the 2025 restructuring event were $4.4 million and as of December 31, 2025, there is $0.6 million left to be paid under the 2025 restructuring event. The final payment will be completed in the third fiscal quarter of 2026.
Note 4—Business Combinations
Ask Sage Acquisition
On December 31, 2025, pursuant to the agreement and plan of merger (“Ask Sage Merger Agreement”), dated November 10, 2025, by and among Atlas 2025 Merger Sub, Inc., a Delaware corporation and a direct wholly-owned subsidiary of the Company (“Ask Sage Merger Sub”) and Ask Sage, Inc., a Delaware corporation (“Ask Sage” or “Seller”) and Shareholder Representative Services LLC, a Colorado limited liability company solely in its capacity as the representative of the Ask Sage Securityholders, pursuant to which, among other matters, (i) Ask Sage Merger Sub merged with and into Ask Sage with Ask Sage Merger Sub ceasing to exist and Ask Sage surviving as a wholly-owned subsidiary of the Company (“Ask Sage Merger”).
Purchase consideration for the Ask Sage Merger and the related transactions as contemplated by the Ask Sage Merger Agreement of $271.6 million, which was subject to customary adjustments for indebtedness, cash, working capital and transaction expenses, was comprised of $262.4 million of cash paid at closing of the Ask Sage Merger, $5.2 million of cash paid shortly after closing, and $4.0 million withheld under the terms of the Ask Sage Merger Agreement at the time of the closing to cover any post-closing downward adjustments to the purchase price (“Adjustment Escrow Amount”). The Company is required to segregate the Adjustment Escrow Amount from its corporate funds and is restricted from using it for operating expenses or any other corporate purposes. The cash withheld for the Adjustment Escrow Amount is presented in restricted cash on the Company’s consolidated balance sheets at December 31, 2025. The Adjustment Escrow Amount is presented in other current liabilities on the Company’s consolidated balance sheets at December 31, 2025.
The following table summarizes the preliminary fair value of the consideration transferred and the preliminary fair values of the major classes of assets acquired and liabilities assumed as of the acquisition date. These fair values were based on management’s estimates and assumptions; however, the amounts indicated above are preliminary in nature and are subject to adjustment as additional information is obtained about the facts and circumstances that existed as of the acquisition date. Accordingly, there may be adjustments to the assigned values of acquired assets and assumed liabilities. All values remain preliminary including, but not limited to, intangible assets, including the preliminary assumptions used in their estimates of fair values and their respective estimated useful lives, working capital accounts, income taxes, and residual goodwill. The final determination of the fair values, purchase consideration, related income tax impacts and residual goodwill will be completed as soon as practicable, and within the measurement period of up to one year from the acquisition date as permitted under GAAP. Any adjustments to provisional amounts that are identified during the measurement period will be recorded in the reporting period in which the adjustment is determined.
| December 31, 2025 | |
|---|---|
| Cash paid at closing | $262,443 |
| Deferred consideration | 5,183 |
| Adjustment Escrow Amount | 4,000 |
| Purchase consideration | $271,626 |
| Assets: | |
| Cash | $33,418 |
| Accounts receivable | 1,331 |
| Prepaid expenses and other current assets | 256 |
| Intangible assets | 84,290 |
| Total assets acquired | $119,295 |
| Liabilities: | |
| Accounts payable | 3,354 |
| Accrued expenses | 3,675 |
| Contract liabilities | 11,622 |
| Other current liabilities | 13 |
| Deferred tax liabilities | 21,660 |
| Total liabilities acquired | $40,324 |
| Fair value of net identifiable assets acquired | 78,971 |
| Goodwill | $192,655 |
The following table summarizes the intangible assets acquired by class and the weighted-average estimated useful lives:
| December 312025 | Weighted-average estimated useful lives | |
|---|---|---|
| Technology | $65,220 | 7 years |
| Licenses and certifications | 5,990 | 7 years |
| Customer relationships | 12,785 | 3 years |
| Trade names | 295 | 1 year |
| Total intangible assets | $84,290 |
The fair value of the acquired technology and trade name was determined using the relief from royalty (“RFR”) method. The fair value of the acquired customer relationships was determined using the excess earnings method. The fair value of the acquired licenses and certifications was determined using the cost replacement method.
The acquisition was accounted for as a business combination, whereby the excess of the purchase consideration over the fair value of identifiable net assets was allocated to goodwill. The goodwill reflects the potential synergies and expansion of the Company’s offerings across product lines and markets complementary to its existing products and markets. For tax purposes, the goodwill related to the acquisition is deductible.
As the Ask Sage Merger closed on December 31, 2025, the net revenues and net loss included in the results of operations are negligible for the year ended December 31, 2025. Transaction expenses of $2.1 million related to the Ask Sage Merger were included in the results of operations for the year ended December 31, 2025.
Pro Forma Financial Data (Unaudited)
The following table presents the pro forma consolidated results of operations of BigBear.ai for the year ended December 31, 2025 as though the acquisition of Ask Sage had been completed as of January 1, 2024.
| Unaudited pro forma for the year ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Revenues | $142,897 | $161,455 |
| Net loss | (299,455) | (308,843) |
The amounts included in the pro forma information are based on the historical results and do not necessarily represent what would have occurred if the Ask Sage business combination had taken place as of January 1, 2024, nor do they represent the results that may occur in the future. Accordingly, the pro forma financial information should not be relied upon as being indicative of the results that would have been realized had the acquisition occurred as of the date indicated or that may be achieved in the future.
The Company incurred $2.1 million of transaction expenses attributable to the acquisition of Ask Sage during the year ended December 31, 2025, which have been recorded in the pro forma results for the twelve months ended December 31, 2024.
Pangiam Acquisition
On February 29, 2024, pursuant to the Agreement and Plan of Merger (the “Pangiam Merger Agreement”), dated November 4, 2023, by and among BigBear.ai, Pangiam Merger Sub, Inc., a Delaware corporation and a direct wholly-owned subsidiary of the Company (“Pangiam Merger Sub”), Pangiam Purchaser, LLC, a Delaware limited liability company and a direct wholly-owned subsidiary of the Company (“Pangiam Purchaser”), Pangiam Ultimate Holdings, LLC, a Delaware limited liability company (the “Seller”), and Pangiam Intermediate Holdings, LLC, a Delaware limited liability company (“Pangiam Intermediate”), (i) Pangiam Merger Sub merged with and into Pangiam Intermediate, with Pangiam Merger Sub ceasing to exist and Pangiam Intermediate surviving as a wholly-owned subsidiary of the Company (the “First Merger”), and (ii) immediately following the First Merger, Pangiam Intermediate merged with and into Pangiam Purchaser, with Pangiam Intermediate ceasing to exist and Pangiam Purchaser continuing as a wholly-owned subsidiary of the Company (the “Second Merger”, together with the First Merger, the “Pangiam Mergers”).
As consideration for the Pangiam Mergers and the related transactions contemplated by the Pangiam Merger Agreement, BigBear.ai issued a total of 61,838,072 shares of the Company’s common stock to Seller based on the 20-day volume-weighted average price for common stock ending on the trading day immediately prior to the date of the Pangiam Merger Agreement of $1.3439, representing an enterprise value of $70 million (which was subject to customary adjustments for indebtedness, cash, working capital and transaction expenses) (the “Purchase Price”), less $3.5 million that was held back from the Purchase Price at the time of the closing of the Pangiam Mergers to cover any post-closing downward adjustments to the Purchase Price (the “Holdback Amount”). On July 2, 2024 (the “Finalization Date”), BigBear.ai issued 2,144,073 shares of common stock at $1.3905 per share (as determined according to the volume weighted average price over the 20 trading days ending immediately prior to the Finalization Date) as settlement of the final determination of the post-close adjusted Purchase Price.
The following table summarizes the final fair value of the consideration transferred and the fair values of the major classes of assets acquired and liabilities assumed as of the acquisition date.
| February 29, 2024, as reported at March 31, 2024 | Measurement period adjustments | February 29, 2024, as reported at December 31, 2024 | |
|---|---|---|---|
| Holdback amount | $3,500 | $(513) | $2,987 |
| Equity issued | 207,776 | (6) | 207,770 |
| Purchase consideration | $211,276 | $(519) | $210,757 |
| Assets: | |||
| Cash | $13,935 | $— | $13,935 |
| Accounts receivable | 5,848 | (369) | 5,479 |
| Prepaid expenses and other current assets | 143 | 150 | 293 |
| Property and equipment | 635 | — | 635 |
| Right-of-use assets | 5,754 | 188 | 5,942 |
| Intangible assets | 39,100 | (1,035) | 38,065 |
| Other non-current assets | 1,772 | — | 1,772 |
| Total assets acquired | $67,187 | $(1,066) | $66,121 |
| Liabilities: | |||
| Accounts payable | 1,137 | — | 1,137 |
| Accrued expenses | 2,454 | 36 | 2,490 |
| Other current liabilities | 69 | (24) | 45 |
| Contract liabilities | 1,148 | — | 1,148 |
| Current portion of long-term lease liability | 1,080 | (874) | 206 |
| Long-term lease liability | 6,109 | (373) | 5,736 |
| Total liabilities acquired | $11,997 | $(1,235) | $10,762 |
| Fair value of net identifiable assets acquired | 55,190 | 169 | 55,359 |
| Goodwill | $156,086 | $(688) | $155,398 |
The following table summarizes the intangible assets acquired by class and the weighted-average estimated useful lives:
| February 292024 | Weighted-average estimated useful lives | |
|---|---|---|
| Technology | $14,835 | 7 years |
| Trade names | 1,560 | 5 years |
| Customer relationships | 21,670 | 20 years |
| Total intangible assets | $38,065 |
The fair value of the acquired technology and trade name was determined using the RFR method. The fair value of the acquired customer relationships was determined using the excess earnings method.
The acquisition was accounted for as a business combination, whereby the excess of the purchase consideration over the fair value of identifiable net assets was allocated to goodwill. The goodwill reflects the potential synergies and expansion of the Company’s offerings across product lines and markets complementary to its existing products and markets. For tax purposes, the goodwill related to the acquisition is deductible.
The following table presents the net revenues, net loss and transaction expenses related to the Pangiam mergers included in the results of operations for the following periods:
| Years Ended December 31, 2024 | |
|---|---|
| Revenues | $38,712 |
| Net loss | (82,595) |
| Transaction expenses related to the Pangiam Acquisition | 1,450 |
Pro Forma Financial Data (Unaudited)
The following table presents the pro forma consolidated results of operations of BigBear.ai for the year ended December 31, 2024 as though the acquisition of Pangiam had been completed as of January 1, 2023.
| Unaudited pro forma for the year ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Revenues | $164,413 | $195,813 |
| Net loss | (242,468) | (84,789) |
The amounts included in the pro forma information are based on the historical results and do not necessarily represent what would have occurred if the Pangiam business combination had taken place as of January 1, 2023, nor do they represent the results that may occur in the future. Accordingly, the pro forma financial information should not be relied upon as being indicative of the results that would have been realized had the acquisition occurred as of the date indicated or that may be achieved in the future.
The Company incurred $1.5 million of transaction expenses attributable to the acquisition of Pangiam during the year ended December 31, 2024, which have been recorded in the pro forma results for the twelve months ended December 31, 2023. The Company incurred $85.0 million of goodwill impairment as outlined in Note 8—Goodwill during the year ended December 31, 2024, which has been recorded in the pro forma results for the year ended December 31, 2024.
Note 5—Fair Value of Financial Instruments
Cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, short-term debt, including the current portion of long-term debt, accrued liabilities and other current liabilities are reflected on the consolidated balance sheets at amounts that approximate fair value because of the short-term nature of these financial assets and liabilities.
Certain warrants that were issued at BigBear.ai’s initial public offering (“IPO Private Warrants”), warrants issued in BigBear.ai’s 2023 and 2024 private placement warrants (“PIPE Warrants”), and warrants issued in BigBear.ai’s 2023, 2024 and 2025 registered direct offering warrants (“RDO Warrants”) are valued using a modified Black-Scholes option pricing model (“OPM”). The conversion options of the 2026 Convertible Notes (“2026 Notes Conversion Option”) and 2029 Convertible Notes (“2029 Notes Conversion Option”) are valued using a binomial lattice convertible bond model and discounted cash flow method, considering the traded price of the 2026 Convertible Notes and 2029 Convertible Notes, respectively, and other unobservable input assumptions. The 2026 Notes Conversion Option, 2029 Notes Conversion Option, IPO Private Warrants, PIPE Warrants and RDO Warrants are considered to be Level 3 fair value measurements. See Note 19—Derivatives for information on the Level 3 inputs used to value the IPO Private Warrants, PIPE Warrants, RDO Warrants, 2026 Notes Conversion Option, and the 2029 Notes Conversion Option.
Valuations of available for sale investments are provided by independent pricing service providers who have experience in valuing these securities and are compared to the average of quoted market prices obtained from independent brokers. These fair value measurements based on quoted prices in markets that are not active or for which all significant inputs are observable, directly or indirectly, and are considered to be Level 2 fair value measurements.
The table below presents the financial assets and liabilities measured at fair value :
| Balance Sheet Caption · Level 1 · Level 2 · Level 3 · Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Recurring fair value measurements: | |||||||||
| Available for sale investments | Available for sale investments | $— | $374,410 | $— | $374,410 | ||||
| 2024 PIPE warrants | Derivative liabilities | — | — | — | — | ||||
| 2024 RDO Warrants | Derivative liabilities | — | — | — | — | ||||
| 2025 RDO Warrants | Derivative liabilities | — | — | 16,437 | 16,437 | ||||
| IPO Private Warrants | Derivative liabilities | — | — | 128 | 128 | ||||
| 2026 Notes Conversion Option | Derivative liabilities | — | — | 1,585 | 1,585 | ||||
| 2029 Notes Conversion Option | Derivative liabilities | — | — | 98,756 | 98,756 | ||||
| Total recurring fair value measurements: | $— | $374,410 | $116,906 | $491,316 | |||||
| Nonrecurring fair value measurement: | |||||||||
| Goodwill(2) | Goodwill | $— | $— | $241,100 | $241,100 | ||||
| Balance Sheet Caption · Level 1 · Level 2 · Level 3 · Total | |||||||||
| Recurring fair value measurements: | |||||||||
| Available for sale investments | Available for sale investments | $— | $— | $— | $— | ||||
| 2024 PIPE Warrants | Derivative liabilities | — | — | 32,760 | 32,760 | ||||
| 2024 RDO Warrants | Derivative liabilities | — | — | 21,634 | 21,634 | ||||
| 2025 RDO Warrants | Derivative liabilities | — | — | — | — | ||||
| IPO Private Warrants | Derivative liabilities | — | — | 290 | 290 | ||||
| 2026 Notes Conversion Option | Derivative liabilities | — | — | 322 | 322 | ||||
| 2029 Notes Conversion Option | Derivative liabilities | — | — | 115,831 | 115,831 | ||||
| Total recurring fair value measurements: | $— | $— | $170,837 | $170,837 | |||||
| Nonrecurring fair value measurement: | |||||||||
| Goodwill(1) | Goodwill | $— | $— | $119,081 | $119,081 | ||||
(1) As of March 31, 2024, in accordance with ASC 350-20, goodwill with a carrying amount of $204.8 million was written down to its implied fair value of $119.1 million, resulting in an impairment charge of $85.0 million, which was included in earnings during the first quarter of 2024. Differences between the implied fair value of $119.1 million and the balance as of December 31, 2024 relate to subsequent measurement period adjustments.
(2) As of June 30, 2025, in accordance with ASC 350-20, goodwill with a carrying amount $119.1 million was written down to its implied fair value of $48.4 million, resulting in an impairment charge of $70.6 million, which was included in earnings during the second quarter of 2025.
The changes in the fair value of the Level 3 liabilities are as follows:
| 2023 PIPE warrants | 2023 RDO warrants | 2024 PIPE warrants | 2024 RDO Warrants | 2025 RDO warrants | IPO private warrants | 2026 Notes Conversion Option | 2029 Notes Conversion Option | |
|---|---|---|---|---|---|---|---|---|
| December 31, 2023 | $22,778 | $15,018 | $— | $— | $— | $66 | $491 | $— |
| Additions | — | — | 27,990 | 15,196 | — | — | — | 61,402 |
| Changes in fair value | 37,361 | 15,551 | 4,770 | 6,438 | — | 227 | (169) | 54,429 |
| Settlements | (60,139) | (30,569) | — | — | — | (3) | — | — |
| December 31, 2024 | $— | $— | $32,760 | $21,634 | $— | $290 | $322 | $115,831 |
| Additions | — | — | — | — | 18,586 | — | — | — |
| Changes in fair value | — | — | (270) | 14,294 | (2,149) | (162) | 1,263 | 79,818 |
| Settlements | — | — | (32,490) | (35,928) | — | — | — | (96,893) |
| December 31, 2025 | $— | $— | $— | $— | $16,437 | $128 | $1,585 | $98,756 |
Note 6—Investments in Debt Securities
The Company’s investments in debt securities comprise U.S. Treasury securities and corporate bonds. As of September 30, 2025, these investments were classified as held-to-maturity (“HTM”) and recorded at amortized cost, net of any allowance for credit losses. The Company purchased these debt securities with the positive intent and ability to hold to contractual maturity.
During December 2025, the Company was unable to obtain shareholder approval to authorize additional outstanding shares in order to satisfy the purchase consideration for the Ask Sage Merger in shares of BigBear common stock. As a result, the Company sold HTM debt securities to settle the purchase consideration in cash. Management concluded this sale qualified for the permitted-sale exception under ASC 320-10-25-9 and did not taint the Company’s remaining HTM debt securities. Subsequent to these events, management reassessed the remaining HTM portfolio and concluded that, based on the facts and circumstances arising in the fourth quarter of 2025, the Company could no longer assert its positive intent to hold the remaining debt securities to maturity. Accordingly, the remaining debt securities were reclassified from HTM to available for sale (“AFS”) during the fourth quarter of 2025. The transferred debt securities had a fair value of $510.5 million, comprising net unrealized gains of $0.4 million. Unrealized gains and losses on AFS investments are reported in other comprehensive (loss) income.
During the year ended December 31, 2025, AFS investments with a fair value of $131.3 million were sold, resulting in a realized gain of $0.3 million, which is presented inother expense (income) on theconsolidated statements of operations and comprehensive loss. There wereno AFS investments as of December 31, 2024 andno sales of AFS investments during the year ended December 31, 2024 and December 31, 2023, respectively.
The table below summarizes the Company’s AFS investments:
| December 31, 2025 | |||||
|---|---|---|---|---|---|
| Available for sale investments | Amortized cost | Allowance for credit losses | Gross unrealized gains | Gross unrealized losses | Fair value |
| U.S. Treasury securities | $131,229 | $— | $123 | $(2) | $131,350 |
| Corporate bonds | 243,028 | — | 129 | (97) | 243,060 |
| Total | $374,257 | $— | $252 | $(99) | $374,410 |
The weighted-average yield of investments is 3.85% as of December 31, 2025. Interest income of $6.0 million wasrecognized duringthe year ended December 31, 2025, and is presented ininterest income on theconsolidated statements of operations and comprehensive loss. No interest income was recognized on the AFS investments duringthe year ended December 31, 2024 and December 31, 2023, respectively.
The table below presents the contractual maturity by major class of AFS investments as of December 31, 2025. In some cases, the issuers may have the right to call obligations without penalties prior to the contractual maturity date.
| Within 1 year · 1 to 5 years · Total | ||||||
|---|---|---|---|---|---|---|
| Balance sheet caption: · Available for sale investments(current assets) · Available for sale investments(non-current assets) | ||||||
| Amortized cost | Fair value | Amortized cost | Fair value | Amortized cost | Fair value | |
| U.S. Treasury securities | $72,075 | $72,116 | $59,154 | $59,234 | $131,229 | $131,350 |
| Corporate bonds | 128,393 | 128,345 | 114,635 | 114,715 | 243,028 | 243,060 |
| Total | $200,468 | $200,461 | $173,789 | $173,949 | $374,257 | $374,410 |
Note 7—Property and Equipment, net
The property and equipment and accumulated depreciation balances are as follows:
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| Computer equipment | $1,957 | $1,564 |
| Furniture and fixtures | 975 | 937 |
| Leasehold improvements | 813 | 714 |
| Office equipment | 180 | 180 |
| Software | 60 | 60 |
| Total cost | 3,985 | 3,455 |
| Less: accumulated depreciation | (2,423) | (1,889) |
| Property and equipment, net | $1,562 | $1,566 |
The table below presents depreciation expense related to property and equipment for the following periods:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Depreciation expense on property and equipment | $534 | $540 | $428 |
Substantially all property and equipment is located within the United States of America.
Note 8—Goodwill
Fiscal 2024
During the first quarter of fiscal 2024, we performed a quantitative impairment analysis as a result of a decrease in the Company’s share price during the quarter compared to the share price of the equity issued as consideration for the purchase of Pangiam as described in Note 4. As a result of this testing, we recorded an $85.0 million non-cash goodwill impairment charge during the three months ended March 31, 2024. Our goodwill impairment test reflected an allocation of 50% and 50% between the income and market-based approaches, respectively. Significant inputs into the valuation models included the discount rate, EBITDA growth and estimated future cash flows. We used a discount rate of 30.7%, guideline peer group and their historical and forward-looking revenues in the goodwill impairment test. Subsequent to the impairment, there wasno excess of reporting unit fair value over carrying value.
Fiscal 2025
During the second quarter of fiscal 2025, we performed a triggering event analysis to determine if it was more likely than not that the fair value of the reporting unit was less than the carrying value. It was determined that there was a triggering event related to the downward revisions of short and long-term forecasts. As a result of this assessment, we performed a quantitative impairment analysis and the Company recorded a $70.6 million non-cash impairment charge during the three months ended June 30, 2025. Our goodwill impairment test reflected an allocation of 50% and 50% between the income and market-based approaches, respectively. Significant inputs into the valuation models included the discount rate, EBITDA growth and estimated future cash flows. We used a discount rate of 12%, guideline peer group and their historical and forward-looking revenues in the goodwill impairment test. Subsequent to the impairment, there wasno excess of reporting unit fair value over carrying value.
We performed our annual goodwill impairment assessment as of the first day of the fourth quarter of 2025 using a qualitative approach to determine if it was more likely than not that the fair value of the reporting unit was less than the carrying value. As part of this evaluation, the Company considered relevant events and circumstances that could affect the estimated fair value of its reporting unit, including macroeconomic conditions, the shut down of the U.S. government, industry and market trends, financial performance, and other entity-specific factors. Based on this qualitative assessment, the Company concluded that it was more likely than not that the fair value of the reporting unit exceeded its carrying amount as of that date. Accordingly, a quantitative impairment test was not performed.
At the beginning of December 2025, a triggering event was identified relative to certain revenue contracts with the U.S. government that resulted in downward revisions of short and long-term forecasts. The facts resulting in the triggering event for the Company’s goodwill were also considered a triggering event for the long-lived assets of the Company’s single asset group. As a result, we first assessed the Company’s long-lived assets for impairment (refer to Note 9—Intangible Assets, net for further information). As a result of the long-lived assets impairment, the carrying amount of the Company’s asset group was reduced to its fair value. As the Company is comprised of a single asset group and reporting unit, there wasno excess of reporting unit fair value over carrying value subsequent to the long-lived asset impairment.
Accumul ated impairment losses to goodwill were$209.2 million as of December 31, 2025.
The table below presents the changes in carrying amount of goodwill:
| As of December 31, 2023 | $48,683 |
|---|---|
| Goodwill arising from the acquisition of Pangiam | 155,398 |
| Goodwill impairment | (85,000) |
| As of December 31, 2024 | $119,081 |
| Goodwill impairment | (70,636) |
| Goodwill arising from the acquisition of Ask Sage | 192,655 |
| As of December 31, 2025 | $241,100 |
Note 9—Intangible Assets, net
At the beginning of December 2025, the Company identified a triggering event related to its asset group and performed a valuation of certain long-lived intangible assets in accordance with ASC 360, Impairment and Disposal of Long-Lived Assets. We calculated the undiscounted cash flows of the Company’s asset group and compared these to its carrying value. As the undiscounted cash flows did not exceed its carrying value, the Company estimated the fair value of the asset group. Our long-lived asset impairment test reflected an allocation of 50% and 50% between the income and market-based approaches, respectively. Significant inputs to the income approach valuation models included the discount rate of 10%, revenue growth, EBITDA growth and estimated future cash flows. Under the market approach,we used historical and forward-looking revenues of a guideline peer group to estimate the fair value of the asset group.
We further estimated the fair value of each long-lived asset within the asset group using theincome approach (within the income approach, various methods are available such as multi-period excess earnings and relief from royalty methods). Significant inputs to the valuation of intangible assets included the discount rate, revenue growth and estimated future cash flows.
As a result, the Company recorded $53.4 million of impairment expense related to its intangible assets. The impairment is presented inimpairment of long-lived assets in theconsolidated statements of operations and comprehensive loss. Subsequent to the impairment, there was no excess of asset group fair value over carrying value.
The intangible asset balances, accumulated amortization, and accumulated impairment are as follows:
| December 31, 2025 | ||||||
|---|---|---|---|---|---|---|
| Grosscarryingamount | Accumulatedamortization | Accumulated impairment | Impact of foreign currency translation | Netcarryingamount | Weightedaverageusefullife in years | |
| Customer relationships | $109,055 | $(20,650) | $(43,264) | $— | $45,141 | 15.2 |
| Licenses and certifications | 5,990 | — | — | — | 5,990 | 7.0 |
| Technology | 106,255 | (22,282) | (9,547) | — | 74,426 | 7.0 |
| Software for sale | 18,020 | (5,258) | — | 361 | 13,123 | 3.0 |
| Trade name | 1,855 | (473) | (592) | — | 790 | 3.5 |
| Total | $241,175 | $(48,663) | $(53,403) | $361 | $139,470 | |
| December 31, 2024 | ||||||
| Grosscarryingamount | Accumulatedamortization | Accumulated impairment | Impact of foreign currency translation | Netcarryingamount | Weightedaverageusefullife in years | |
| Customer relationships | $96,270 | $(16,064) | $— | $— | $80,206 | 20.0 |
| Technology | 41,035 | (16,665) | — | — | 24,370 | 7.0 |
| Software for sale | 14,459 | (927) | — | (289) | 13,243 | 3.0 |
| Trade name | 1,560 | (260) | — | — | 1,300 | 5.0 |
| Total | $153,324 | $(33,916) | $— | $(289) | $119,119 | |
The table below presents all amortization and impairment expense related to all intangible assets as well as amortization expense related to capitalized software for the following periods:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Total amortization expense related to intangible assets | $14,747 | $11,327 | $7,473 |
| Total impairment expense related to intangible assets | 53,403 | — | — |
| Amortization expense related to capitalized software | $4,331 | $925 | $— |
The table below presents the estimated amortization expense on intangible assets for the next five years and thereafter as of December 31, 2025:
| 2026 | $25,383 |
| 2027 | 23,791 |
| 2028 | 20,094 |
| 2029 | 13,393 |
| 2030 | 13,292 |
| Thereafter | 43,517 |
| Total estimated amortization expense | $139,470 |
Note 10—Prepaid Expenses and Other Current Assets
The table below presents details on prepaid expenses and other current assets:
| December 31,2025 | December 31,2024 | |
|---|---|---|
| Accrued interest receivable | $4,125 | $129 |
| Prepaid software and subscriptions | 2,322 | 2,074 |
| Prepaid insurance | 2,270 | 1,021 |
| Prepaid marketing | 1,697 | — |
| Prepaid taxes | 94 | 249 |
| Other prepaid expenses | 732 | 295 |
| Pre-contract costs(1) | 3,274 | — |
| Total prepaid expenses and other current assets | $14,514 | $3,768 |
(1) Costs incurred to fulfill a contract in advance of the contract being awarded are included in prepaid expenses and other current assets if we determine that those costs relate directly to a contract or to an anticipated contract that we can specifically identify and contract award is probable, the costs generate or enhance resources that will be used in satisfying performance obligations, and the costs are recoverable (referred to as pre-contract costs).
Note 11—Accrued Liabilities
The table below presents details on accrued liabilities:
| December 312025 | December 312024 | |
|---|---|---|
| Payroll accruals(1) | $12,090 | $13,533 |
| Accrued interest | 356 | 231 |
| Legal accruals | 275 | 450 |
| Other accrued expenses | 6,771 | 5,283 |
| Impact of foreign currency translation | 157 | (1) |
| Total accrued liabilities | $19,649 | $19,496 |
(1) Inclusive of employer portion of taxes related to the vesting of equity awards and accrued subcontractor labor.
Note 12—Debt
The table below presents the Company’s debt balances:
| December 312025 | December 31, 2024 | |
|---|---|---|
| 2026 Convertible Notes | $17,668 | $17,668 |
| 2029 Convertible Notes | 124,605 | 182,332 |
| D&O Financing Loan | — | 818 |
| Total debt | 142,273 | 200,818 |
| Less: unamortized debt issuance discount and costs | 35,229 | 64,596 |
| Total debt, net | 107,044 | 136,222 |
| Less: current portion | 16,560 | 818 |
| Long-term debt, net | $90,484 | $135,404 |
2026 Convertible Notes
On December 7, 2021, the Company issued $200.0 million of unsecured convertible notes (the“2026 Convertible Notes”) to certain investors. The 2026 Convertible Notes bear interest at a rate of 6.0% per annum, payable semi-annually, and not including any interest payments that are settled with the issuance of shares, were initially convertible into 17,391,304 shares of the Company’s common stock at an initial conversion price of $11.50 (the “Conversion Price”). The Conversion Price is subject to adjustments. On May 29, 2022, pursuant to the 2026 Convertible Notes indenture, the conversion rate applicable to the 2026 Convertible Notes was adjusted to 94.2230 (previously 86.9565) shares of common stock per $1,000 principal amount of 2026 Convertible Notes because the average of the daily volume-weighted average price of the common stock during the preceding 30 trading days was less than $10.00 (the “Conversion Rate Reset”). After giving effect to the Conversion Rate Reset, the Conversion Price is $10.61 and the 2026 Convertible Notes are convertible into 18,844,600 shares, not including any interest payments that are settled with the issuance of shares. The 2026 Convertible Note financing matures on December 15, 2026.
The Company may, at its election and subject to certain conditions, force conversion of the 2026 Convertible Notes after December 15, 2022 and prior to October 7, 2026 if the trading price of the Company’s common stock exceeds 130% of the conversion price for 20 out of the preceding 30 trading days and the 30-day average daily trading volume ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to $3.0 million for the firsttwo years after the initial issuance of the 2026 Convertible Notes and $2.0 million thereafter. In connection with such forced conversion, the conversion rate for the 2026 Convertible Notes will be increased but no Interest Make-Whole Payment (as defined below) will be made in connection with such forced conversion. In the event that a holder of the 2026 Convertible Notes elects to convert the 2026 Convertible Notes (a) prior to December 15, 2024, the Company will be obligated to pay an amount equal totwelve months of interest or (b) on or after December 15, 2024 but prior to December 15, 2025, any accrued and unpaid interest plus any remaining amounts that would be owed up to, but excluding, December 15, 2025 (such interest payments, an “Interest Make-Whole Payments”). The Interest Make-Whole Payments will be payable in cash or shares of the common stock, depending on the average of the daily volume-weighted average price per share of the Company’s common stock for a specified period immediately prior to such conversion, as set forth in the Indenture.
Following certain corporate events that occur prior to the maturity date or if the Company exercises its mandatory conversion right, the conversion rate will be increased in certain circumstances for a holder who elects, or has been forced, to convert its 2026 Convertible Notes in connection with such corporate events or such mandatory conversion.
If a Fundamental Change (as defined in the 2026 Convertible Notes indenture) occurs prior to the maturity date, holders of the 2026 Convertible Notes will have the right to require the Company to repurchase all or any portion of their 2026 Convertible Notes in principal amounts ofone thousand dollars or an integral multiple thereof, at a repurchase price equal to the principal amount of the 2026 Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the repurchase date.
On May 29, 2022, pursuant to the conversion rate adjustment provisions in the indenture, governing the 2026 Convertible Notes, the Conversion Price was adjusted to $10.61 (or 94.2230 shares of common stock perone thousand dollars of principal amount of Convertible Notes). Subsequent to the adjustment, the 2026 Convertible Notes are convertible into 18,844,600 shares, not including any interest payments that are settled with the issuance of shares.
The 2026 Convertible Notes contain conversion features that meet the definition of a derivative and require separate accounting treatment from the debt host. Refer to Note 19—Derivatives for more information on the 2026 Notes Conversion Option.
On December 19, 2024, the Company entered into privately negotiated exchange agreements (each, an “Exchange Agreement”) with a limited number of holders of the Company’s 2026 Convertible Notes, to exchange the 2026 Convertible Notes for new senior secured convertible notes due 2029 (the “2029 Convertible Notes”, together with the 2026 Convertible Notes, the “Convertible Notes”). The Company exchanged (the “Exchange Transaction”) approximately $124.6 million principal amount of the 2026 Convertible Notes for $182.3 million in aggregate principal amount of the Company’s 2029 Convertible Notes and approximately $0.4 million in cash, with such cash payment representing the accrued and unpaid interest on the 2026 Convertible Notes at the time of the Exchange Transaction. The 2029 Convertible Notes bear interest at a rate of (i)6.0% per annum, if interest is paid in cash and (ii)7.0% per annum, if the Company elects, subject to certain conditions, to pay interest in kind with shares of its common stock. To the extent that the certain liquidity conditions of the Company and its subsidiaries is not satisfied as of the last business day of any calendar month, then with respect to the period applicable to the interest payment date immediately following the month in which such liquidity condition is not satisfied, the interest rate will be (i)9.00% per annum, if interest is paid in cash and (ii)10.00% per annum, if the Company elects, subject to certain conditions, to pay interest in kind with shares of its common stock (it being understood that such increased rate shall apply solely for such six-month period applicable to such interest payment date). Interest is payable semi-annually. The conversion rate is 281.4491 shares of common stock per $1,000 principal amount of 2029 Convertible Notes, which represents an initial conversion price of $3.55 per share of the Company’s common stock. The conversion rate and the conversion price are subject to adjustments. In addition, if certain corporate events that constitute a “Make-Whole Fundamental Change” (as defined in the 2029 Convertible Notes Indenture) occur, then the conversion rate will, in certain circumstances, be increased for a specified period of time.
The exchange was accounted for as an extinguishment of the 2026 Convertible Notes and the 2029 Convertible Notes were recognized at fair value, which approximated the carrying amount of the principal balances exchanged. For the year ended December 31, 2024, the Company recognized a loss on extinguishment of $31.3 million on the consolidated statements of operations related to the unamortized debt issuance costs of the exchanged 2026 Convertible Notes. The Company was in compliance with all covenants through the extinguishment of the exchanged 2026 Convertible Notes.
The 2029 Convertible Notes were issued pursuant to, and are governed by, an indenture (the “2029 Convertible Notes Indenture”), dated as of December 27, 2024. The 2029 Convertible Notes will be fully and unconditionally guaranteed, on a senior, secured basis, by the Company and certain of its existing and future direct and indirect subsidiaries, subject to certain exceptions (the “Guarantors”), and will initially be secured on a first-priority basis by substantially all assets of the Company and such Guarantors, subject to certain exceptions.
Upon completion of the Exchange Transaction, the aggregate principal amount of the 2026 Convertible Notes outstanding was $17.7 million. The Company did not receive any cash proceeds from the issuance of the 2029 Convertible Notes pursuant to the Exchange Transactions.
Holders who convert their 2029 Convertible Notes will also be entitled to an interest make-whole payment of up to 7.5% of the aggregate principal amount of notes converted, subject to reduction as further described in the 2029 Convertible Notes Indenture. Interest make-whole payments are payable in cash or shares of common stock, depending on the average of the daily volume-weighted average price per share of the Company’s common stock for a specified period immediately prior to such conversion. Payment of the interest make-whole in shares will be at a price equal to 95% of such average of the daily volume-weighted average price.
The 2029 Convertible Notes will not be redeemable at the Company’s election before December 27, 2025. The 2029 Convertible Notes will be redeemable, in whole but not in part (subject to certain limitations), for cash at the Company’s option at any time, and from time to time, on or after December 27, 2025 and prior to the close of business on November 16, 2029, but only if the last reported sale price per share of the Company’s common stock exceeds 130% of the conversion price for a specified period of time and certain other conditions are satisfied. The redemption price will be equal to the principal amount of the 2029 Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.
If a Fundamental Change (as defined in the 2029 Convertible Notes Indenture) occurs, holders of the 2029 Convertible Notes will have the right to require the Company to repurchase their 2029 Convertible Notes for cash in principal amounts of the 2029 Convertible Notes to be repurchased ofone thousand dollars, plus accrued and unpaid interest, if any, to, but excluding, the applicable repurchase date, plus any remaining amounts that would be owed to, but excluding, the maturity date.
The 2026 Convertible Notes and the 2029 Convertible Notes require the Company to meet certain financial and other covenants. As of December 31, 2025, the Company was in compliance with all covenants related to the Convertible Notes.
The 2029 Convertible Notes contain conversion features that meet the definition of a derivative and require separate accounting treatment from the debt host. Refer to Note 19—Derivatives for more information on the 2029 Notes Conversion Option.
During the three months ended March 31, 2025, $57.7 million of the 2029 Convertible Notes were voluntarily converted by noteholders following the Exchange Transaction. These conversions have resulted in the issuance of 16.7 million shares of common stock.
The following table presents the carrying amounts and fair values associated with the Convertible Notes as of December 31, 2025. The fair value of the Convertible Notes is considered to be a Level 3 fair value measurement.
| Outstanding balance | Unamortized issuance costs and debt discount | Carrying value | Fair value | |
|---|---|---|---|---|
| 2026 Convertible Notes | $17,668 | $(1,108) | $16,560 | $16,879 |
| 2029 Convertible Notes | 124,605 | (34,121) | 90,484 | 106,086 |
| Total | $142,273 | $(35,229) | $107,044 | $122,965 |
The table below summarizes the components of interest expense for the following periods:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Contractual interest expense | $9,059 | $12,219 | $12,182 |
| Amortization of debt discount and deferred financing costs | 9,057 | 13,428 | 12,695 |
| Total interest expense | $18,116 | $25,647 | $24,877 |
D&O Financing Loan
On December 13, 2024, the Company entered into a $1.1 million loan (the“2025 D&O Financing Loan”) with AFCO Credit Corporation to finance the Company’s directors and officers insurance premium through September 2025. The D&O Financing Loan had an interest rate of 5.99% per annum and matured on September 8, 2025.
Note 13—Leases
The Company is obligated under operating leases for certain real estate and office equipment assets. The Company’s finance leases are not material. Certain leases contained predetermined fixed escalation of minimum rents at rates ranging from 2.5% to 10.0% per annum and remaining lease terms of up toten years, some of which include renewal options that could extend certain leases to up to an additional five years.
The following table presents supplemental information related to leases:
| December 31,2025 | December 31,2024 | |
|---|---|---|
| Weighted average remaining lease term | 6.59 | 8.06 |
| Weighted average discount rate | 14.59% | 13.52% |
The table below summarizes total lease costs for the following periods:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Operating lease expense | $2,052 | $2,139 | $1,149 |
| Variable lease expense | 160 | 47 | 221 |
| Short-term lease expense | 58 | 18 | 117 |
| Lease expense | $2,270 | $2,204 | $1,487 |
| Years Ended December 31, | |||
| 2025 | 2024 | 2023 | |
| Sublease income (1) | $291 | $72 | $133 |
(1)As of December 31, 2025 and December 31, 2024, the Company has subleased four andtwo of its real estate leases, respectively.
The following table presents supplemental cash flow and non-cash information related to leases:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cash paid for amounts included in the measurement of lease liabilities - operating cash flows from leases | $2,321 | $2,199 | $1,430 |
| Right-of-use assets obtained in exchange for lease obligations - non-cash activity | $378 | $5,942 | $— |
As of December 31, 2025, the future annual minimum lease payments for operating leases are as follows:
| 2026 | $2,158 |
| 2027 | 1,554 |
| 2028 | 1,523 |
| 2029 | 1,552 |
| 2030 | 1,773 |
| Thereafter | 4,219 |
| Total future minimum lease payments | $12,779 |
| Less: amounts related to imputed interest | 5,011 |
| Present value of future minimum lease payments | 7,768 |
| Less: current portion of long-term lease liability | 1,095 |
| Long-term lease liability | $6,673 |
Note 14—Income Taxes
The components of loss before taxes were attributable to the following regions:
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Domestic loss | $(315,296) | $(296,010) | $(70,879) |
| Foreign (loss) income | (340) | 207 | — |
| Loss before taxes | $(315,636) | $(295,803) | $(70,879) |
The table below presents the components of income tax benefit for the following periods
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Current: | |||
| U.S. federal | $— | $— | $— |
| U.S. state and local | 25 | 16 | 13 |
| Foreign | (87) | (235) | — |
| Total current | (62) | (219) | 13 |
| Deferred: | |||
| U.S. federal | (17,701) | — | (323) |
| U.S. state and local | (3,959) | (37) | 88 |
| Total deferred | (21,660) | (37) | (235) |
| Income tax benefit | $(21,722) | $(256) | $(222) |
The following table provides the reconciliation of the amounts computed using the U.S. federal statutory income tax rate and the amounts computed using the effective income tax rate under the requirements of ASU 2023-09 forthe year ended December 31, 2025. Refer to Note 2—Summary of Significant Accounting Policies—Recent Accounting Pronouncements Adopted for additional details on the adoption of ASU 2023-09:
| Years Ended December 31, 2025 | ||
|---|---|---|
| Amount | % | |
| Tax benefit at U.S. federal statutory rates | $(66,236) | 21.0% |
| U.S. state and local income taxes, net of U.S. federal income tax effect(1) | (3,934) | 1.2% |
| Foreign tax effects | ||
| United Kingdom | ||
| Statutory tax rate difference between United Kingdom and United States | 9 | —% |
| Other | (140) | —% |
| Changes in valuation allowance | 41,936 | (13.3)% |
| Nontaxable or Nondeductible Items | ||
| Equity-based compensation | (6,103) | 1.9% |
| Non-deductible compensation | 1,819 | (0.6)% |
| Non-deductible debt interest | 1,831 | (0.6)% |
| Net increase in fair value of derivatives | 2,460 | (0.8)% |
| Goodwill impairment | 6,599 | (2.1)% |
| Other | 37 | —% |
| Income tax benefit and effective tax rate | $(21,722) | 6.7% |
(1)State taxes in Virginia and New Jersey made up the majority (greater than 50%) of the tax effect in this category.
The following table provides the reconciliation of the amounts computed using the U.S. federal statutory income tax rate and the amounts computed using the effective income tax rate as previously disclosed for the years ended December 31, 2024 and December 31, 2023, prior to the adoption of ASU 2023-09:
| Years Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Amount | Amount | |
| Tax benefit at U.S. federal statutory rates | $(62,118) | $(14,881) |
| U.S. state income tax, net of U.S. federal tax benefit | (11,422) | (5,070) |
| Class B Incentive Unit equity-based compensation | (4) | 727 |
| Valuation allowance | 46,739 | 17,248 |
| Net increase in fair value of derivatives | 11,281 | 1,559 |
| Goodwill impairment | 15,544 | — |
| Other permanent differences | (276) | 195 |
| Income tax benefit | $(256) | $(222) |
| Effective tax rate | 0.1% | 0.3% |
The table below presents the components of net deferred tax assets and deferred liabilities:
| December 31,2025 | December 31, 2024 | |
|---|---|---|
| Deferred tax assets: | ||
| Net operating loss carryforwards | $101,923 | $62,811 |
| Interest carryforwards | 12,621 | 12,755 |
| Amortizable transaction costs | 2,479 | 2,121 |
| Accrued expenses | 1,727 | 1,643 |
| Equity-based compensation | 4,185 | 3,175 |
| Derivative liability | 34,073 | 30,824 |
| Depreciation and amortization | 8,569 | 7,083 |
| Lease liabilities | 2,186 | 2,741 |
| Section 174 costs | 7,788 | 8,327 |
| Other assets | 110 | 109 |
| Total deferred tax assets | 175,661 | 131,589 |
| Valuation allowance | (160,454) | (112,003) |
| Net deferred tax assets | 15,207 | 19,586 |
| Deferred tax liabilities: | ||
| Depreciation and amortization | — | — |
| Discount on debt | 11,021 | 16,340 |
| Prepaid expenses | 2,222 | 752 |
| Right-of-use assets | 1,964 | 2,494 |
| Total deferred tax liabilities | 15,207 | 19,586 |
| Net deferred tax (liabilities) assets | $— | $— |
As of December 31, 2025, the Company has $339.6 million of U.S. federal net operating losses, all of which can be carried forward indefinitely.
As of December 31, 2025, the Company has $426.6 million of U.S. state net operating losses which will begin to expire in 2031.
Pursuant to Internal Revenue Code §382, the Company experienced an ownership change on December 2, 2024, as defined under §382(g). As a result, $170.6 million of federal net operating losses and $41.5 million of interest expense carryforward generated prior to that date are subject to limitation of $52.9 million per year through 2028.
A valuation allowance is provided for deferred income tax assets when it is more likely than not that future tax benefits will not be realized. The Company assesses whether a valuation allowance should be established against deferred tax assets based upon consideration of all available evidence, both positive and negative, using a more likely than not standard. This assessment considers, among other matters, the Company’s history of losses, the duration of statutory carryforward periods, the Company’s experience with tax attributes expiring, impacts of enacted changes in tax laws and tax planning strategies, and the taxable income generated through the future reversals of deferred tax liabilities. In making such judgments, significant weight is given to evidence that can be objectively verified. After analyzing all available evidence, the Company determined it was more likely that it would not be able to utilize all of its deferred tax assets, and has therefore established a full valuation allowance. The Company had valuation allowances against net deferred tax assets of $160.5 million and $112.0 million as of December 31, 2025 and December 31, 2024, respectively. During the year ended December 31, 2025, the increase in the valuation allowance was primarily attributable to net operating losses.
The table below presents the change of the valuation allowance for the following periods:
| Valuation allowance as of December 31, 2023 | $46,569 |
|---|---|
| Net additions | 65,434 |
| Valuation allowance as of December 31, 2024 | $112,003 |
| Net additions | 70,111 |
| Reduction due to acquired deferred tax liabilities of Ask Sage | (21,660) |
| Valuation allowance as of December 31, 2025 | $160,454 |
Unrecognized Tax Benefits
As of December 31, 2025 and December 31, 2024, the Company had gross unrecognized tax benefits of $0.8 million and $0.8 million, respectively. The unrecognized tax benefit was recorded as a reduction in our gross deferred tax assets, offset by a corresponding reduction in our valuation allowance. None of the unrecognized tax benefits, if recognized, would affect the effective tax rate because of the valuation allowance. There areno interest and penalties associated with the unrecognized tax benefits. For the year ended December 31, 2025 and prior periods, we were subject to income taxes only in the United States, and all tax years since the Company’s inception are open for examination.
The table below presents the Company’s gross unrecognized tax benefits:
| Unrecognized tax benefits as of December 31, 2023 | $785 |
|---|---|
| Increases related to positions taken on prior year items | — |
| Unrecognized tax benefits as of December 31, 2024 | $785 |
| Increases related to positions taken on prior year items | — |
| Unrecognized tax benefits as of December 31, 2025 | $785 |
Note 15—Employee Benefit Plans
401(k) Plans
The Company maintains qualified 401(k) plans for its U.S. employees: the BigBear.ai 401(k) Plan, the Pangiam Holdings, LLC Retirement Plan and the Ask Sage, Inc. 401(k) Plan.
On January 1, 2025, all of the assets from the Pangiam Holdings, LLC Retirement Plan were transferred into the BigBear.ai 401(k) Plan.
The table below presents the total contributions to the Company’s 401(k) plan for the following periods:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Total contributions | $5,791 | $5,010 | $4,684 |
Note 16—Commitments and Contingencies
Contingencies in the Normal Course of Business
Under certain contracts with the U.S. government and certain governmental entities, contract costs, including indirect costs, are subject to audit by and adjustment through negotiation with governmental representatives. Revenue is recorded in amounts expected to be realized on final settlement of any such audits.
The Company is subject to litigation, claims, investigations and audits arising from time to time in the ordinary course of business. Although legal proceedings are inherently unpredictable, the Company intends to defend itself vigorously with respect to any matters currently pending against it. The outcome of these matters, individually and in the aggregate, is not expected to have a material impact on the Company’s consolidated balance sheets, consolidated statements of operations, or cash flows. As of December 31, 2025, the Company has accrued $0.3 million related to various ongoing legal disputes. The $0.3 million balance as of December 31, 2025, reflects management’s best estimate as of that date and is net of any anticipated amounts recoverable through insurance.
Note 17—Stockholders’ Equity
Common Stock
The table below presents the details of the Company’s authorized common stock as of the following periods:
| December 31,2025 | December 31,2024 | |
|---|---|---|
| Common stock: | ||
| Authorized shares of common stock | 500,000,000 | 500,000,000 |
| Common stock par value per share | $0.0001 | $0.0001 |
| Common stock outstanding at the period end | 436,955,655 | 251,554,378 |
Treasury Stock
These shares are measured at cost and presented as treasury stock on the consolidated balance sheets and consolidated statements of stockholders’ equity (deficit).
Dividend Rights
Subject to applicable law and the rights, if any, of the holders of any outstanding series of the Company’s preferred stock or any class or series of stock having a preference over or the right to participate with the Company’s common stock with respect to the payment of dividends, dividends may be declared and paid ratably on the Company’s common stock out of the assets of the Company that are legally available for this purpose at such times and in such amounts as the Company’s Board of Directors (the “Board”) in its discretion shall determine.
Voting Rights
Each outstanding share of the Company’s common stock is entitled toone vote on all matters submitted to a vote of stockholders. Holders of shares of common stock do not have cumulative voting rights.
Conversion or Redemption Rights
The Company’s common stock is neither convertible nor redeemable.
Liquidation Rights
Upon the Company’s liquidation, the holders of the Company’s common stock are entitled to receive pro rata the Company’s assets that are legally available for distribution, after payment of all debts and other liabilities and subject to the prior rights of any holders of the Company’s preferred stock then outstanding.
Preferred Stock
The table below presents the details of the Company’s authorized preferred stock as of the following periods:
| December 31,2025 | December 31,2024 | |
|---|---|---|
| Preferred stock: | ||
| Authorized shares of preferred stock | 1,000,000 | 1,000,000 |
| Preferred stock par value per share | $0.0001 | $0.0001 |
| Preferred stock outstanding at the period end | — | — |
The Company’s Board may, without further action by the Company’s stockholders, from time to time, direct the issuance of shares of preferred stock in series and may, at the time of issuance, determine the designations, powers, preferences, privileges and relative participating, optional or special rights as well as the qualifications, limitations or restrictions thereof, including dividend rights, conversion rights, voting rights, terms of redemption and liquidation preferences, any or all of which may be greater than the rights of the Company’s common stock. Satisfaction of any dividend preferences of outstanding shares of the Company’s preferred stock would reduce the amount of funds available for the payment of dividends on shares of the Company’s common stock. Upon the affirmative vote of a majority of the total number of directors then in office, the Company’s Board may issue shares of the Company’s preferred stock with voting and conversion rights which could adversely affect the holders of shares of the Company’s common stock.
Note 18—At-the-Market Offering
In April 2023, the Company filed an automatic shelf registration statement on Form S-3 (the “2023 Shelf Registration Statement”) with the SEC registering an indeterminate amount of its common stock, preferred stock, warrants, rights, and units (collectively, “Company securities”), which the SEC declared effective on April 21, 2023. Pursuant to the Company’s controlled equity offering agreement (the “Controlled Equity Offering Agreement”) dated as of May 10, 2024, with Cantor Fitzgerald & Co. (“Cantor”), as sales agent, under an “at the market” offering program (the “ATM Program”), the Company agreed to pay commissions to Cantor as its sales agent for their service with respect to the sales of common stock through the ATM Program.
Pursuant to the Controlled Equity Offering Agreement, the Company may offer and sell common stock from time to time to or through Cantor, subject to the Company’s compliance with applicable laws and the applicable requirements of the Controlled Equity Offering Agreement. The Controlled Equity Offering Agreement stipulates that the Company will pay Cantor a commission of up to 3.0% of the gross offering proceeds of any shares of common stock sold to or through Cantor pursuant to the Controlled Equity Offering Agreement. The Company intends to use the net proceeds from sales of common stock issued under the ATM Program for general corporate and working capital purposes. The timing of any sales and the number of shares sold will depend on a variety of factors to be determined and considered by the Company. The Company is not obligated to sell any shares under the Controlled Equity Offering Agreement.
In May 2024, the Company filed a prospectus supplement to the 2023 Shelf Registration Statement which allows the Company to sell, from time to time and at its discretion, Company securities having an aggregate offering price of up to $150 million including shares of common stock that may be sold pursuant to the Company’s Controlled Equity Offering Agreement (the “May 2024 Sales Agreement”).
In June 2025, the Company filed a prospectus supplement to the 2023 Shelf Registration Statement which allows the Company to sell, from time to time and at its discretion, Company securities having an aggregate offering price of up to $150 million including shares of common stock that may be sold pursuant to the Company’s Controlled Equity Offering Agreement (the “June 2025 Sales Agreement”).
In August 2025, the Company filed a prospectus supplement to the 2023 Shelf Registration Statement which allows the Company to sell, from time to time and at its discretion, Company securities with a maximum of shares sold totaling 65 million, including shares of common stock that may be sold pursuant to the Company’s Controlled Equity Offering Agreement (the “August 2025 Sales Agreement”).
The following table summarizes the terms and provisions of each sales agreement, and each Common Stock ATM Offering that was active during the year ended December 31, 2025 and the year ended December 31, 2024. The maximum aggregate offering price and cumulative net proceeds (less sales commissions and expenses) for each Common Stock ATM Offering in the following table are reported in thousands.
| Agreement effective date | May 2024 Sales Agreement | June 2025 Sales Agreement | August 2025 Sales Agreement |
|---|---|---|---|
| Maximum aggregate offering price ($ thousands) | $150,000 | $150,000 | $— |
| Maximum commissions payable to sales agents on gross proceeds from sale of shares | 3.0% | 3.0% | 0.9% |
| Expiration date / date substantially depleted | May 28,2025 | June 16,2025 | September 16,2025 |
| As of December 31, 2025: | |||
| Cumulative gross proceeds received from shares sold under such sales agreement ($ thousands) | $150,000 | $150,000 | $337,073 |
| Maximum aggregate offering price remaining available for sale under such sales agreement. | $— | $— | $— |
The following table summarizes the sales activity of each sales agreement that was active during 2025 or 2024 for the periods indicated. The net proceeds (less sales commissions and expenses) for each Common Stock ATM Offering in the following table are reported in thousands.
| Years Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Number of shares sold under such sales agreement: | ||
| May 2024 Sales Agreement | 39,555,415 | — |
| June 2025 Sales Agreement | 37,697,898 | — |
| August 2025 Sales Agreement | 65,000,000 | — |
| Total shares sold pursuant to Common Stock ATM Offerings | 142,253,313 | — |
| Net proceeds received from shares sold under such sales agreement ($ thousands): | ||
| May 2024 Sales Agreement | $147,375 | $— |
| June 2025 Sales Agreement | 147,375 | — |
| August 2025 Sales Agreement | 334,039 | — |
| Total net proceeds received from shares sold pursuant to Common Stock ATM Offerings | $628,789 | $— |
The sales commissions and expenses related to each of the above Common Stock ATM Offerings are considered direct and incremental costs and are charged against additional paid-in capital on the consolidated balance sheets in the period in which the corresponding shares are issued and sold.
Note 19—Derivatives
2026 Notes Conversion Option
On December 7, 2021, the Company issued $200 million of unsecured convertible notes (the“2026 Convertible Notes”) to certain investors. The 2026 Convertible Notes contain conversion features that meet the definition of a derivative and require separate accounting treatment from the debt host.
The table below presents the value of the 2026 Notes Conversion Option under the Binomial Lattice Model using the following assumptions as of the following dates:
| December 31,2025 | December 31,2024 | |
|---|---|---|
| Value of 2026 Notes Conversion Option ($ thousands) | $1,585 | $322 |
| Conversion price (dollars) | $10.61 | $10.61 |
| Common stock price (dollars) | $5.40 | $4.45 |
| Expected option term (years) | 0.9 | 1.9 |
| Expected volatility | 110.00% | 93.30% |
| Risk-free rate of return | 3.50% | 4.25% |
| Expected annual dividend yield | —% | —% |
As of December 31, 2025, the 2026 Notes Conversion Option had a fair value of $1.6 million and is presented on theconsolidated balance sheets within derivative liabilities. The following was recognized as a result of the change in fair value and is presented in net increase in fair value of derivatives on the consolidated statements of operations and comprehensive loss:
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (Loss) gain on change in fair value of 2026 Notes Conversion Option | $(1,263) | $169 | $63 |
As of December 31, 2025, the remaining principal of the 2026 Convertible Notes outstanding was$17.7 million.
2029 Notes Conversion Option
On December 19, 2024, the Company entered into privately negotiated Exchange Agreements with a limited number of holders of the Company’s 2026 Convertible Notes, to exchange the 2026 Convertible Notes for 2029 Convertible Notes. The 2029 Convertible Notes contain conversion features that meet the definition of a derivative and require separate accounting treatment from the debt host.
The table below presents the value of the 2029 Notes Conversion Option under the Binomial Lattice Model as of December 31, 2024 and the as-converted basis as of December 31, 2025 using the following assumptions as of the following dates:
| December 31,2025 | December 31,2024 | |
|---|---|---|
| Value of 2029 Notes Conversion Option ($ thousands) | $98,756 | $115,831 |
| Conversion price (dollars) | $3.55 | $3.55 |
| Common stock price (dollars) | $5.40 | $4.45 |
| Expected option term (years) | 4.0 | 5.0 |
| Expected volatility | N/A | 37.60% |
| Risk-free rate of return | 3.60% | 4.30% |
| Expected annual dividend yield | —% | —% |
During the year ended December 31, 2025, $57.7 million of the 2029 Convertible Notes were voluntarily converted by noteholders following the Exchange Transaction. These conversions resulted in the issuance of approximately 16.7 million shares of common stock in exchange for the retirement of the respective notes. Upon conversion of the notes, there was a mark-to-market adjustment to increase the debt conversion option derivative liability, resulting in a loss of $59.9 million, which is presented in net increase in fair value of derivatives on the consolidated statements of operations and comprehensive loss. In conjunction with the conversion, a loss of$2.6 million was recognized related to the convertible debt discount and unamortized deferred financing costs, and is presented in loss on extinguishment of debt on the consolidated statements of operations.
As of December 31, 2025, the 2029 Notes Conversion Option had a fair value of $98.8 million and is presented on theconsolidated balance sheets within derivative liabilities. The following was recognized as a result of the change in fair value and is presented in net increase in fair value of derivatives on the consolidated statements of operations and comprehensive loss:
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Loss on change in fair value of 2029 Notes Conversion Option | $(79,818) | $(54,429) | $— |
As of December 31, 2025, the remaining principal of the 2029 Convertible Notes outstanding was$124.6 million.
2023 RDO Warrants
On June 13, 2023, the Company consummated the closing of a registered direct offering pursuant to an Underwriting Agreement with Cowen and Company, LLC, as representative of the underwriters, for the sale and purchase of an aggregate of 11,848,341 shares of common stock at par value and accompanying common warrants (“RDO warrants”). Each share of common stock is accompanied by a common warrant to purchase three-quarters of a share of common stock at an exercise price of $2.32 per share. The RDO warrants were initially exercisable for up to 8,886,255 shares of common stock and became exercisablesix months after issuance and had afive-year term.
The table below presents the value of the PIPE warrants under the Black-Scholes Option Pricing Model using the following assumptions as of the following dates:
| December 312023 | June 132023 | |
|---|---|---|
| Value of each 2023 RDO warrant (dollars) | $1.69 | $1.96 |
| Exercise price (dollars) | $2.32 | $2.32 |
| Common stock price (dollars) | $2.14 | $2.3 |
| Expected option term (years) | 5.0 | 5.5 |
| Expected volatility | 110.00% | 118.60% |
| Risk-free rate of return | 3.80% | 4.00% |
| Expected annual dividend yield | —% | —% |
On February 27, 2024, the Company entered into a warrant exercise agreement (the “RDO Warrant Exercise Agreement”) with an existing accredited investor (the “RDO Investor”) to exercise in full the outstanding RDO warrants to purchase up to an aggregate of 8,886,255 shares of the Company’s common stock for gross proceeds of $20.6 million. Upon settlement of the RDO warrants, a loss of$10.1 million was recognized for the year ended December 31, 2024 and is presented in net increase in fair value of derivatives on the consolidated statements of operations and comprehensive loss.
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (Loss) gain on change in fair value of 2023 RDO warrants | $— | $(15,551) | $518 |
2024 RDO Warrants
In consideration for the immediate and full exercise of the RDO warrants, on February 28, 2024, the RDO Investor received a new unregistered common stock purchase warrant to purchase up to an aggregate of 5,800,000 of the Company’s common stock (the “2024 RDO warrants”) in a private placement. The 2024 RDO warrants became exercisablesix months after issuance and had afive-year term, with an exercise price per share equal to$3.78.
The table below presents the value of the 2024 RDO warrants under the Black-Scholes OPM using the following assumptions as of the following dates:
| December 312024 | February 28,2024 | |
|---|---|---|
| Value of each 2024 RDO warrant (dollars) | $3.73 | $2.62 |
| Exercise price (dollars) | $3.78 | $3.78 |
| Common stock price (dollars) | $4.45 | $3.14 |
| Expected option term (years) | 4.7 | 5.5 |
| Expected volatility | 120.00% | 117.60% |
| Risk-free rate of return | 4.31% | 4.20% |
| Expected annual dividend yield | —% | —% |
On February 5, 2025, the Company entered into a warrant exercise agreement (the “RDO Warrant Exercise Agreement”) with an existing accredited investor (the “RDO Investor”) to exercise in full the outstanding 2024 RDO warrants to purchase up to an aggregate of 5,800,000 shares of the Company’s common stock for gross proceeds of$21.9 million. Upon settlement of the RDO warrants, a loss of $14.3 million was recognized for the year ended December 31, 2025 and is presented in net increase in fair value of derivatives on the consolidated statements of operations and comprehensive loss.
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Loss on change in fair value of 2024 RDO Warrants | $(14,294) | $(6,438) | $— |
2025 RDO Warrants
In consideration for the immediate and full exercise of the 2024 RDO warrants, on February 5, 2025, the RDO Investor received a new unregistered common stock purchase warrant to purchase up to an aggregate of 3,770,000 of the Company’s common stock (the “2025 RDO warrants”) in a private placement. The 2025 RDO warrants will become exercisablesix months after issuance and have afive-year term, with an exercise price per share equal to$9.00.
The table below presents the value of the 2025 RDO warrants under the Black-Scholes OPM using the following assumptions as of the following dates:
| December 31,2025 | February 6,2025 | |
|---|---|---|
| Value of each 2025 RDO warrant (dollars) | $4.36 | $4.93 |
| Exercise price (dollars) | $9.00 | $9.00 |
| Common stock price (dollars) | $5.40 | $6.77 |
| Expected option term (years) | 4.6 | 5.5 |
| Expected volatility | 130.00% | 95.00% |
| Risk-free rate of return | 3.66% | 4.25% |
| Expected annual dividend yield | —% | —% |
As of December 31, 2025, the 2025 RDO warrants had a fair value of $16.4 million and is presented on theconsolidated balance sheets within derivative liabilities. The following was recognized as a result of the change in fair value and is presented in net increase in fair value of derivatives on the consolidated statements of operations and comprehensive loss:
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Gain on change in fair value of 2025 RDO Warrants | $2,149 | $— | $— |
As of December 31, 2025, there were 3,770,000 2025 RDO warrants issued and outstanding.
2023 PIPE Warrants
On January 19, 2023, the Company consummated the closing of a private placement (the “Private Placement”) by and among the Company and Armistice Capital Master Fund Ltd (the “Purchaser”). At the closing of the Private Placement, the Company issued 13,888,889 shares of the Company’s common stock at par value and warrants to purchase up to an additional 13,888,889 shares of common stock (the “PIPE warrants”). The PIPE warrants became exercisablesix months after issuance and had afive-year term, with an exercise price of $2.39 per share. The PIPE warrants were subject to a 4.99% beneficial ownership limitation.
The table below presents the value of the PIPE warrants under the Black-Scholes OPM using the following assumptions as of the following dates:
| December 312023 | January 192023 | |
|---|---|---|
| Value of each 2023 PIPE warrant (dollars) | $1.64 | $1.22 |
| Exercise price (dollars) | $2.39 | $2.39 |
| Common stock price (dollars) | $2.14 | $1.87 |
| Expected option term (years) | 4.6 | 5.5 |
| Expected volatility | 110.00% | 82.10% |
| Risk-free rate of return | 3.80% | 3.40% |
| Expected annual dividend yield | —% | —% |
On March 4, 2024, the Company entered into a warrant exercise agreement (the “PIPE Warrant Exercise Agreement”) with an existing accredited investor (the “PIPE Investor”) to exercise in full the outstanding PIPE warrants to purchase up to an aggregate of 13,888,889 shares of the Company’s common stock for gross proceeds of$33.2 million. Upon settlement of the PIPE warrants, a loss of $32.2 million was recognized for the year ended December 31, 2024 and is presented in net increase in fair value of derivatives on the consolidated statements of operations and comprehensive loss.
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Loss on change in fair value of 2023 PIPE Warrants | $— | $(37,361) | $(7,885) |
2024 PIPE Warrants
In consideration for the immediate and full exercise of the 2023 PIPE warrants, on March 5, 2024, the PIPE Investor received a new unregistered common stock purchase warrant to purchase up to an aggregate of 9,000,000 shares of the Company’s common stock (the “2024 PIPE warrant”) in a private placement. The 2024 PIPE warrants became exercisablesix months after issuance and had afive-year term, with an exercise price per share equal to$4.75.
The table below presents the value of the 2024 PIPE warrants under the Black-Scholes OPM using the following assumptions as of the following dates:
| December 31,2024 | March 4,2024 | |
|---|---|---|
| Value of each 2024 PIPE warrant (dollars) | $3.64 | $3.11 |
| Exercise price (dollars) | $4.75 | $4.75 |
| Common stock price (dollars) | $4.45 | $3.75 |
| Expected option term (years) | 4.7 | 5.5 |
| Expected volatility | 120.00% | 117.00% |
| Risk-free rate of return | 4.32% | 4.10% |
| Expected annual dividend yield | —% | —% |
On February 10, 2025, the Company entered into a warrant exercise agreement (the “PIPE Warrant Exercise Agreement”) with an existing accredited investor (the “PIPE Investor”) to exercise 4,500,000 of the outstanding PIPE warrants to purchase up to an aggregate of 9,000,000 shares of the Company’s common stock for gross proceeds of$21.4 million. Upon settlement of the PIPE warrants, a gain of $0.3 million was recognized as a result of the change in fair value for the twelve months ended December 31, 2025 and is presented in net increase in fair value of derivatives on the consolidated statements of operations and comprehensive loss.
On February 11, 2025, the Company entered into an additional PIPE Warrant Exercise Agreement with the same PIPE Investor to exercise the remaining 4,500,000 of the outstanding PIPE warrants to purchase up to an aggregate of 9,000,000 shares of the Company’s common stock for gross proceeds of$21.4 million. Upon settlement of the PIPE warrants, a gain of $0.1 million was recognized as a result of the change in fair value for the year ended December 31, 2025 and is presented in net increase in fair value of derivatives on the consolidated statements of operations and comprehensive loss.
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Gain (loss) on change in fair value of 2024 PIPE Warrants | $270 | $(4,770) | $— |
IPO Public Warrants
Each warrant issued in connection with the Company’s initial public offering (the “IPO public warrants”) entitles the registered holder to purchaseone share of common stock at a price of $11.50 per share, subject to adjustment. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares of common stock. This means only a whole warrant may be exercised at a given time by a warrant holder. The warrants will expire on December 7, 2026, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
The Company may call the IPO public warrants for redemption as follows: (1) in whole and not in part; (2) at a price of $0.01 per warrant; (3) upon a minimum of 30 days’ prior written notice of redemption; (4) if there is an effective registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus available throughout the 30-day notice period; and (5) only if the last reported closing price of the common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
If the Company calls the IPO public warrants for redemption, management will have the option to require all holders that wish to exercise the Company IPO public warrants to do so on a “cashless basis.”
The exercise price and number of shares of common stock issuable upon exercise of the IPO public warrants may be adjusted in certain circumstances including stock dividends, stock splits, extraordinary dividends, consolidation, combination, reverse stock split or reclassification of shares of the Company’s common stock or other similar event. In no event will the Company be required to net cash settle the warrant shares.
The table below presents the Company’s IPO public warrants issued and outstanding as of the following periods:
| December 31,2025 | December 31,2024 | |
|---|---|---|
| IPO public warrants issued | 12,252,439 | 12,168,378 |
| IPO public warrants outstanding | 12,252,439 | 12,168,378 |
IPO Private Warrants
The terms and provisions of the IPO public warrants above also apply to the private warrants issued by the Company (“IPO private warrants”). If the IPO private warrants are held by holders other than GigAcquisitions4, LLC (“Sponsor”), Oppenheimer & Co. Inc. and Nomura Securities International, Inc. (together, the“Underwriters”), or any respective permitted transferees, the IPO private warrants will be redeemable by the Company and exercisable by the holders on the same basis as the IPO public warrants. The Sponsor, the Underwriters and any respective permitted transferees have the option to exercise the IPO private warrants on a cashless basis.
The table below presents the value of the IPO private warrants under the Black-Scholes OPM using the following assumptions as of the following dates:
| December 31,2025 | December 31,2024 | |
|---|---|---|
| Fair value of each IPO private warrant | $1.75 | $1.84 |
| Exercise price | $11.50 | $11.50 |
| Common stock price | $5.40 | $4.45 |
| Expected option term (in years) | 0.9 | 1.9 |
| Expected volatility | 140.00% | 93.30% |
| Risk-free rate of return | 3.46% | 3.60% |
| Expected annual dividend yield | —% | —% |
As of December 31, 2025 and December 31, 2024, the IPO private warrants have a fair value of $0.1 million and $0.3 million and are presented on the consolidated balance sheets within derivative liabilities. The following was recognized as a result of the change in fair value and is presented in net increase in fair value of derivatives on the consolidated statements of operations and comprehensive loss:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Gain (loss) on change in fair value of IPO private warrants | $162 | $(266) | $(57) |
The table below presents the Company’s IPO private warrants issued and outstanding as of the following periods:
| December 31,2025 | December 31,2024 | |
|---|---|---|
| IPO private warrants issued | 73,333 | 157,394 |
| IPO private warrants outstanding | 73,333 | 157,394 |
Note 20—Equity-Based Compensation
Class B Unit Incentive Plan
In February 2021, the Company’s former parent, BBAI Ultimate Holdings, LLC (“Former Parent”) adopted a compensatory benefit plan (the“Class B Unit Incentive Plan”) to provide incentives to directors, managers, officers, employees, consultants, advisors and/or other service providers of the Company’s Former Parent or its Subsidiaries in the form of the Former Parent’s Class B Units (“Incentive Units”). Incentive Units have a participation threshold of $1.00 and are divided into three tranches
(“Tranche I,” “Tranche II,” and “Tranche III”). Tranche I Incentive Units are subject to performance-based, service-based and market-based conditions. The grant date fair value for the Incentive Units was $5.19 per unit.
The assumptions used in determining the fair value of the Incentive Units at the grant date are as follows:
| February 16,2021 | |
|---|---|
| Volatility | 57.0% |
| Risk-free interest rate | 0.1% |
| Expected time to exit (in years) | 1.6 |
On July 29, 2021, the Company’s Former Parent amended the Class B Unit Incentive Plan so that the Tranche I and the Tranche III Incentive Units immediately became fully vested, subject to continued employment or provision of services, upon the closing of the transaction stipulated in the Agreement and Plan of Merger (the“Gig Business Combination Agreement”) dated June 4, 2021. The Company’s Former Parent also amended the Class B Unit Incentive Plan so that the Tranche II Incentive Units will vest on any liquidation event, as defined in the Class B Unit Incentive Plan, rather than only upon the occurrence of an Exit Sale, subject to the market-based condition stipulated in the Class B Unit Incentive Plan prior to its amendment.
Equity-based compensation for awards with performance conditions is based on the probable outcome of the related performance condition. The performance conditions required to vest per the amended Incentive Plan remain improbable until they occur due to the unpredictability of the events required to meet the vesting conditions. As such events are not considered probable until they occur, recognition of equity-based compensation for the Incentive Units is deferred until the vesting conditions are met. Once the event occurs, unrecognized compensation cost associated with the performance-vesting Incentive Units (based on their modification date fair value) will be recognized based on the portion of the requisite service period that has been rendered.
The modification date fair value of the Incentive Units was $9.06 per unit. The assumptions used in determining the fair value of the Incentive Units at the modification date are as follows:
| July 29,2021 | |
|---|---|
| Volatility | 46.0% |
| Risk-free interest rate | 0.2% |
| Expected time to exit (in years) | 1.2 |
The volatility used in the determination of the fair value of the Incentive Units was based on analysis of the historical volatility of guideline public companies and factors specific to the Company.
On December 7, 2021, the previously announced Gig Business Combination was consummated. As a result, the Tranche I and Tranche III Incentive Units immediately became fully vested and the performance condition for the Tranche II Incentive Units was met. The fair value determined at the date of the amendment of the Class B Unit Incentive Plan was immediately recognized as compensation expense on the vesting date for Tranches I and III. Compensation expense for the Tranche II Incentive Units is recognized over the derived service period of 30 months from the modification date. The remaining compensation expense for the Tranche II Incentive Units will be recognized over the remaining service period of approximately 25 months from the date of the amendment. During the year ended December 31, 2022, the Company’s Former Parent modified the vesting conditions forfour former employees. Under the original terms of the grant agreements, Incentive Units are forfeited upon separation. Due to the amended agreement, the Incentive Units held by the former employees are no longer contingent upon service and are considered vested as of the separation dates. The former employees will not receive the awards until the market condition is achieved. The result of the amended agreement is an accounting modification that resulted in 100% of the compensation expense being recognized for the former employees based on the modification date fair value. The incremental compensation cost recognized as a result of the modification was $1.5 million during the year ended December 31, 2022.
During the year ended December 31, 2025, the Company’s Former Parent disposed of its interest in BigBear. The liquidity event triggered the measurement of the market-related conditions of the unvested Tranche II Incentive Units. The market conditions were not met, and as a result, all unvested Incentive Units were forfeited.
The table below presents the activity in Tranche II of the Incentive Units:
| Unvested as of December 31, 2023 | 1,155,000 |
|---|---|
| Unvested as of December 31, 2024 | 1,155,000 |
| Forfeited | (1,155,000) |
| Unvested as of End of period 2025 | — |
As of December 31, 2025, there wasno unrecognized compensation cost related to Tranche II Incentive Units.
Stock Options
On December 7, 2021, the Company adopted the BigBear.ai Holdings, Inc. 2021 Long-Term Incentive Plan (the“Plan”). The purpose of the Plan is to promote the long-term success of the Company and the creation of stockholder value by providing eligible employees, prospective employees, consultants and non-employee directors of the Company the opportunity to receive stock- and cash-based incentive awards.
During the year ended December 31, 2025, pursuant to the Plan, the Company’s Board of Directors granted certain grantees stock options (“Stock Options”) to purchase shares of the Company’s common stock at a weighted-average exercise price of$3.18. The Stock Options vest over four years with 25% vesting on the one year anniversary of the grant date and 6.25% vesting on the last day of each calendar quarter thereafter until the grant is fully vested. Vesting is contingent upon continued employment or service to the Company and is accelerated in the event of death, disability, or a change in control, subject to certain conditions; both the vested and unvested portion of a Grantee’s Stock Options will be immediately forfeited and cancelled if the Grantee ceases employment or service to the Company. The Stock Options expire on the 10 th anniversary of the grant date.
The table below presents the fair value of Stock Options that were granted during the year ended December 31, 2025 using the Black-Scholes OPM and the following assumptions:
| Number of Stock Options granted | 671,141 |
|---|---|
| Price of common stock on the grant date | $3.39 |
| Expected option term (in years) | 6.1 |
| Expected volatility(1) | 120% |
| Risk-free rate of return | 4.45% |
| Expected annual dividend yield | —% |
| Fair value of the Stock Options on the grant date | $2.98 |
(1)Expected volatility is based on a combination of implied and historical equity volatility of selected reasonably similar publicly traded companies.
The table below presents the activity and other information on the outstanding stock options:
| Stock Options Outstanding · Weighted-Average Exercise Price Per Share · Weighted-Average Remaining Contractual Life (in years) · Aggregate Intrinsic Value | |||||
|---|---|---|---|---|---|
| Outstanding as of December 31, 2023 | 5,127,673 | $2.14 | 9.03 | $2,209 | |
| Granted | — | — | |||
| Vested | — | — | |||
| Exercised | (292,496) | 1.44 | |||
| Forfeited | (826,308) | 2.35 | |||
| Expired | (78,267) | 3.08 | |||
| Outstanding as of December 31, 2024 | 3,930,602 | $2.12 | 8.01 | $10,138 | |
| Granted | 671,141 | 3.18 | |||
| Vested | — | — | |||
| Exercised | (1,899,055) | 1.93 | |||
| Forfeited | (967,350) | 1.66 | |||
| Expired | — | — | |||
| Outstanding as of December 31, 2025 | 1,735,338 | $2.80 | 7.56 | $4,684 | |
| Vested and exercisable as of December 31, 2025 | 935,546 | $2.57 | 6.51 | $3,059 | |
| As of | |||||
| Unrecognized compensation costs related to the stock options | $1,575 | ||||
| Weighted average recognition period for unrecognized compensation costs | 2.89 years | ||||
Restricted Stock Units
During the year ended December 31, 2025, pursuant to the Plan, the Company’s Board communicated the key terms and committed to grant Restricted Stock Units (“RSUs”) to certain employees and certain nonemployee directors and consultants. The Company granted 7,633,500 RSUs to employees and 366,727 RSUs to nonemployee directors during the year ended December 31, 2025. RSUs granted to employees generally vest over four years, with 25% vesting on the one year anniversary of the grant date and then 6.25% per each quarter thereafter on the two, three and four year anniversary of the grant date. RSUs granted to nonemployee directors vest 25% each quarter following the grant date or 100% upon the first anniversary of the grant date. Vesting of RSUs is accelerated in the event of death, disability, or a change in control, subject to certain conditions.
The table below presents the activity and other information on the outstanding RSUs:
| RSUsOutstanding · Weighted-Average Grant Date Fair Value Per Share | |||
|---|---|---|---|
| Unvested as of December 31, 2023 | 10,052,113 | $2.11 | |
| Granted | 10,641,780 | 2.10 | |
| Vested | (4,671,720) | 2.18 | |
| Forfeited | (2,151,771) | 2.29 | |
| Unvested as of December 31, 2024 | 13,870,402 | $1.94 | |
| Granted | 8,000,227 | 3.24 | |
| Vested | (5,745,489) | 2.16 | |
| Forfeited | (4,293,038) | 2.06 | |
| Unvested as of December 31, 2025 | 11,832,102 | $2.73 | |
| As of | |||
| Unrecognized compensation costs related to the RSUs | $27,330 | ||
| Weighted average recognition period for unrecognized compensation costs | 2.26 years | ||
Performance Stock Units
Pursuant to the Plan, the Company’s Board communicated the key terms and granted Performance Stock Units (“PSUs”) to certain employees. The Company grants PSUs to certain employees with performance measures specific to the role of that employee or as a retention incentive (“Discretionary PSUs”). During the year ended December 31, 2025, the Company granted zero Discretionary PSUs. The Company granted 2,740,577 Short-term Incentive PSUs (“STI PSUs”) to employees, which contain performance measures based on a combination of Company’s financial performance as well as the individual’s personal performance. The number of STI PSUs that will vest is based on the achievement of the performance criteria during each respective annual measurement period, provided that the employees remain in continuous service on each vesting date. Vesting will not occur unless a minimum performance criteria threshold is achieved.
During the year ended December 31, 2025, the Board approved grants of 991,548 and 1,749,029 PSUs to certain employees related to STIP PSUs for the 2024 and 2025 plan years, respectively. The 2024 STIP PSUs were granted in lieu of cash payouts and were fully vested upon award.
The table below presents the activity and other information on the outstanding PSUs:
| PSUsOutstanding · Weighted-Average Grant Date Fair Value Per Share | |||
|---|---|---|---|
| Unvested as of December 31, 2023 | 2,585,831 | $1.70 | |
| Granted | 3,703,146 | 5.00 | |
| Vested | (2,559,844) | 1.45 | |
| Forfeited | (795,517) | 6.61 | |
| Unvested as of December 31, 2024 | 2,933,616 | $2.88 | |
| Granted | 2,740,577 | 3.68 | |
| Vested | (2,795,576) | 2.97 | |
| Forfeited | (47,619) | 3.46 | |
| Unvested as of December 31, 2025 | 2,830,998 | $3.37 | |
| As of | |||
| Unrecognized compensation costs related to the PSUs | $1,192 | ||
| Weighted average recognition period for unrecognized compensation costs | 0.24 years | ||
Employee Share Purchase Plan (“ESPP”)
Concurrently with the adoption of the Plan, the Company’s Board adopted the 2021 Employee Stock Purchase Plan (the “ESPP”), which authorizes the grant of rights to purchase common stock of the Company to employees, officers and directors (if they are otherwise employees) of the Company. As of December 31, 2025, the Company reserved an aggregate of 5,260,346 common shares (subject to annual increases on January 1 of each year and ending in 2031) of the Company’s common stock for grants under the ESPP. During the year ended December 31, 2025,961,771 shares were sold under the ESPP. As of December 31, 2025, the Company has withheld employee contributions of$0.2 million for future ESPP purchases, which are presented on theconsolidated balance sheets within other current liabilities.
Equity-based compensation expense related to purchase rights issued under the ESPP is based on the Black-Scholes OPM fair value of the estimated number of awards as of the beginning of the offering period. Equity-based compensation expense is recognized using the straight-line method over the offering period.
The table below presents the assumptions used to estimate the grant date fair value of the purchase rights under the ESPP:
| Years Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Price of common stock on the grant date | $3.95 to $6.05 | $1.50 to $2.20 |
| Expected term (in years) | 0.50 | 0.50 |
| Expected volatility(1) | 130.0% to 110.0% | 122.9% to 101.0% |
| Risk-free rate of return | 4.3% to 3.8% | 5.3% to 4.3% |
| Expected annual dividend yield | —% | —% |
| Fair value of the award on the grant date | $1.99 to $2.76 | $0.74 to $2.15 |
(1)Expected volatility is based on a combination of implied and historical equity volatility of selected reasonably similar publicly traded companies.
As of December 31, 2025, there was approximately$0.7 million of unrecognized compensation costs related to the ESPP, which is expected to be recognized over the remaining weighted average period of 0.50 years years.
Equity-based Compensation Expense
The table below presents the total equity-based compensation expense recognized for Class B Units, Stock Options, RSUs, PSUs, and ESPP in selling, general and administrative expense, cost of revenues, and research and development for the following periods:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Equity-based compensation expense in selling, general and administrative | $12,913 | $12,088 | $11,349 |
| Equity-based compensation expense in cost of revenues | 7,820 | 6,274 | $5,446 |
| Equity-based compensation expense in research and development | 2,597 | 2,765 | 1,876 |
| Total equity-based compensation expense | $23,330 | $21,127 | $18,671 |
Note 21—Net Loss Per Share
The numerators and denominators of the basic and diluted netloss per share are computed as follows (in thousands, except per share, unit and per unit data):
| Years Ended December 31, | |||
|---|---|---|---|
| Basic and diluted net loss per share | 2025 | 2024 | 2023 |
| Numerator: | |||
| Net loss | $(293,914) | $(295,547) | $(70,657) |
| Denominator: | |||
| Basic | 358,801,375 | 233,604,500 | 149,234,917 |
| Diluted | 358,801,375 | 233,604,500 | 149,234,917 |
| Basic net loss per share | $(0.82) | $(1.27) | $(0.47) |
| Diluted net loss per share | $(0.82) | $(1.27) | $(0.47) |
The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Stock options | 1,459,593 | 4,086,187 | 5,005,889 |
| Private warrants | 73,333 | 140,726 | 174,894 |
| Public warrants | 12,252,439 | 12,185,046 | 12,150,878 |
| 2023 PIPE warrants | — | — | 13,888,889 |
| 2024 PIPE warrants | — | 9,000,000 | — |
| 2023 RDO warrants | — | — | 8,886,255 |
| 2024 RDO warrants | — | 5,800,000 | — |
| 2025 RDO warrants | 3,770,000 | — | — |
| 2026 Convertible notes | 1,664,732 | 99,867 | 18,844,600 |
| 2029 Convertible notes | 35,069,965 | 51,317,177 | — |
| PSUs | 1,635,807 | 793,781 | 678,552 |
| RSUs | 13,322,794 | 4,723,239 | 9,359,923 |
| ESPP | 489,023 | 1,288,536 | 1,128,675 |
| Total | 69,737,686 | 89,434,559 | 70,118,555 |
Although certain convertible notes were converted during the year ended December 31, 2025, application of the if-converted method would have been anti-dilutive due to the Company’s net loss for the period; accordingly, such instruments were excluded from diluted earnings per share.
As described in Note 24—Subsequent Events, on January 2, 2026, the Company announced that all 2029 Convertible Notes outstanding as of January 16, 2026 (the “Redemption Date”), would be redeemed for cash at a price equal to the principal amount of such notes plus accrued and unpaid interest, as provided by the terms of the Exchange Agreement. All of the 2029 Convertible Notes were voluntarily converted by noteholders prior to the Redemption Date, resulting in the issuance of approximately 38.1 million shares of common stock.
Note 22—Revenues
Substantially all revenues were generated within the United States of America.
The table below presents total revenues by contract type for the following periods:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Time and materials | $78,437 | $88,740 | $85,734 |
| Firm fixed price | 31,613 | 46,259 | 50,100 |
| Cost-reimbursable | 17,622 | 23,237 | 19,330 |
| Total revenues | $127,672 | $158,236 | $155,164 |
The table below presents the revenue recognition pattern for the following periods:
| Years Ended December 31, 2025 | Years Ended December 31, 2024 | Years Ended December 31, 2023 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Point in Time | Over Time | Total Revenue | Point in Time | Over Time | Total Revenue | Point in Time | Over Time | Total Revenue | |
| All revenue streams | $8,298 | $119,374 | $127,672 | $7,294 | $150,942 | $158,236 | $9,583 | $145,581 | $155,164 |
The table below presents total revenues by major customer type for the following periods:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| U.S. government | $114,686 | $143,087 | $145,182 |
| Non-U.S. government and commercial | 12,986 | 15,149 | 9,982 |
| Total revenues | $127,672 | $158,236 | $155,164 |
The table below summarizes the activity in the allowance for expected credit losses:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Beginning balance | $127 | $230 | $98 |
| Additions | 351 | 125 | 1,739 |
| Write-offs | (40) | (228) | (1,607) |
| Recoveries | — | — | — |
| Ending balance | $438 | $127 | $230 |
Concentration of Risk
Revenue earned from customers contributing in excess of 10% of total revenues are presented in the tables below for the following periods:
| Years Ended December 31, 2025 | ||
|---|---|---|
| Total | Percent of totalrevenues | |
| Customer A(1) | $— | —% |
| Customer B(1) | 10,640 | 8% |
| Customer C | 16,945 | 13% |
| Customer D | 13,831 | 11% |
| Customer E | 20,728 | 16% |
| Customer F | 13,600 | 11% |
| All others | 51,928 | 41% |
| Total revenues | $127,672 | 100% |
| Years Ended December 31, 2024 | ||
|---|---|---|
| Total | Percent of totalrevenues | |
| Customer A | $21,284 | 13% |
| Customer B | 25,681 | 16% |
| Customer C | 18,731 | 12% |
| Customer D(1) | — | —% |
| Customer E | 16,840 | 11% |
| Customer F(1) | — | —% |
| All others | 75,700 | 48% |
| Total revenues | $158,236 | 100% |
| Years Ended December 31, 2023 | ||
| Total | Percent of totalrevenues | |
| Customer A | $33,266 | 21% |
| Customer B | 24,560 | 16% |
| Customer C | 18,143 | 12% |
| Customer D(1) | 14,197 | 9% |
| Customer E(1) | — | —% |
| Customer F(1) | — | —% |
| All others | 64,998 | 42% |
| Total revenues | $155,164 | 100% |
(1) Customers that contributed in excess of 10% of consolidated revenues in any period presented have been included in all periods presented for comparability.
As of December 31, 2025, the Company had one customer with an accounts receivable balance of $3.4 million, which exceeds 10% of total accounts receivable. As of December 31, 2024, no individual customer had an accounts receivable balances that exceeded 10% of total accounts receivable.
Contract Balances
The table below presents the contract assets and contract liabilities included on the consolidated balance sheets for the following periods:
| December 31,2025 | December 31,2024 | December 31,2023 | |
|---|---|---|---|
| Accounts receivable, net of allowance for credit losses | $22,703 | $38,953 | $21,949 |
| Contract assets | $218 | $895 | $4,822 |
| Contract liabilities | $14,756 | $2,541 | $879 |
We receive payments from customers based on a billing schedule as established in our contracts. Contract assets relate to our conditional right to consideration for our completed performance under the contract. Accounts receivables are recorded when the right to consideration becomes unconditional. Contract liabilities relates to payments received in advance of performance under a contract. Contract liabilities are recognized as revenue as (or when) we perform under the contract. Included in the contract liabilities balance as of December 31, 2025 are $11.6 million of contract liabilities from our acquisition of Ask Sage. Refer to Note 4—Business Combinations. Revenue recognized in the year ended December 31, 2025 that was included in thecontract liability balance as of December 31, 2024 was$2.3 million. Revenue recognized in the year ended December 31, 2024 that was included in thecontract liability balance as of December 31, 2023 was$0.9 million.
When the Company’s estimate of total costs to be incurred to satisfy a performance obligation exceeds the expected revenue, the Company recognizes the loss immediately. When the Company determines that a change in estimate has an impact on the associated profit of a performance obligation, the Company records the cumulative positive or negative adjustmentin the consolidated statements of operations and comprehensive loss. Changes in estimates and assumptions related to the status of certain long-term contracts may have a material effect on the Company’s operating results.
The following table summarizes the impact of the net estimates at completion (“EAC”) adjustments on the Company’s operating results:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net EAC Adjustments, before income taxes | $4,347 | $626 | $593 |
| Net EAC Adjustments, net of income taxes(1) | $4,347 | $626 | $593 |
| Net EAC Adjustments, net of income taxes, per diluted share | $0.01 | $— | $— |
(1) Due to the Company being in a net taxable loss position for all periods presented, the impact of income taxes is insignificant.
Remaining Performance Obligations
The Company includes in its computation of remaining performance obligations customer orders for which it has accepted signed sales orders and generally includes the funded and unfunded components of contracts that have been awarded. As of December 31, 2025, the aggregate amount of the transaction price allocated to remaining performance obligations was $8.2 million. The Company expects to recognize approximately 74% of its remaining performance obligations as revenue within the next 12 months and the balance thereafter assuming completion of these contracts without any reductions in scope or termination.
Note 23—Segments
The Company has determined that it operates in a single operating and reportable segment as the Chief Operating Decision Maker (“CODM”) reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. The Company’s segment provides predictive analytics capabilities in highly complex, distributed, mission-based operating environments. It is a technology-led solutions organization, providing both software and services to our customers. The Company’s CODM is its Chief Executive Officer.
Consolidatednet loss, as reported on theconsolidated statements of operations and comprehensive lossas consolidatednet loss, is the primary measure of segment profitability used by the CODM to assess performance and to allocate resources to the segment. Consolidatednet loss is used to monitor budget versus actual results. The monitoring of budgeted versus actual results is used in assessing performance of the segment and in establishing management’s compensation. All expense categories on the consolidated statements of operations and comprehensive loss are significant and there are no other significant segment expenses that would require disclosure or are regularly provided to the CODM.
The measure of segment assets is reported on theconsolidated balance sheets as total consolidated assets. Assets provided to the CODM are consistent with those reported on theconsolidated balance sheets.
Note 24—Subsequent Events
The Company has evaluated subsequent events from the date of the consolidated balance sheets through the date the consolidated financial statements were issued on March 2, 2026.
On January 2, 2026, the Company announced that all 2029 Convertible Notes outstanding as of January 16, 2026 (the “Redemption Date”), would be redeemed for cash at a price equal to the principal amount of such notes plus accrued and unpaid interest, as provided by the terms of the Exchange Agreement. All of the 2029 Convertible Notes, with a par value of $124.6 million, were voluntarily converted by noteholders prior to the Redemption Date. These conversions resulted in the issuance of approximately 38.1 million shares of common stock in exchange for the retirement of the respective notes.
Acquisition of CargoSeer
On January 16, 2026, the Company acquired certain assets and liabilities of CargoSeer Ltd (“CargoSeer”), an Israel-based leader in unified AI decision support technology for customs and border operations, for $5.0 million, subject to certain customary net working capital adjustments. As of the date the consolidated financial statements were issued, the Company had not completed the purchase accounting.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.